Cell Culture Media Market by Reagent Type (Albumin {Bovine, Serum Albumin, Human Serum Albumin, Recombinant Human Serum Albumin}, Hormones, Attachment Factors, Amino Acid, Growth factors and Cytokines {Tumor Necrosis Factors, Insulin - Like Growth Factors, Interferons}, Interleukins); by Type (Chemically-Defined Media, Classical Media, Lysogeny Broth, Protein-Free Media, Serum-Free Media, Specialty Media); by Application (Biopharmaceuticals and Therapeutics, Biotech Research, Cancer, Drug Screening and Drug Development, Regenerative Medicine and Tissue Engineering, Stem Cell Technologies); by End User (Biotechnology and Pharmaceutical Companies, Research Laboratories, Academic Institutes, Pathology Labs); by Region (U.S., Rest of North America, France, UK, Germany, Spain, Italy, Rest of Europe, China, Japan, India, Southeast Asia, Rest of Asia Pacific, GCC Countries, Southern Africa, Rest of MEA, Brazil, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2018-2026’
Industry Trends
Cell culture media generally comprises of an appropriate source of energy and compounds which regulate the cell cycle. A typical culture medium is composed of amino acids, vitamins, inorganic salts, glucose, and serum as a source of growth factors, hormones, and attachment factors. In addition to nutrients, the medium also helps in maintaining the pH and osmolality. There are two types of cell culture media available, artificial and natural. Natural media consists solely of naturally occurring biological fluids. They are used for a wide range of animal cell culture. On the other hand, artificial or synthetic media are prepared by adding nutrients, vitamins, salts, O2 and CO2 gas phases, serum proteins, carbohydrates and cofactors.
Cell Culture Media Market, By Region, 2018 – 2026, (USD Million)
In terms of revenue, the global cell culture media market was US$ 676.1 Mn in 2017 and is estimated to be US$ 993.25 Mn by 2022.
Cell Culture Media Market, by Application
Cell Culture media has its highest application in biopharmaceuticals and therapeutics. It has been used mainly for treatment of Rheumatoid Arthritis, Crohn’s Disease, Psoriasis, Multiple Sclerosis (MS), Systemic Lupus Erythematosus and many others. It also finds application in the field of dermatology. The most famous derma roller treatment used for removing scars from human skin uses a patient’s cell media extracted from his blood to fill up the scars created by past injuries. As media is rich in protein, it stimulates release of collagen, a compound that inhibits new skin formation. Several such cell culture medias are even used in fasciotomy, hair transplants as well as in various skin grafting surgeries.
Cell Culture Media Market, by Region
The region of North America is expected to gain growth in cell culture media market owing to high technological advancements. The region has witnessed the introduction of new cell culture technologies and protocols with ongoing technological advancements such as multi-faceted bioprocessing systems, the development of 3D cell culture, and automated cell culture instruments. The increasing emphasis on intensive research and development activities to widen the scope of applications in carcinogenesis, mutagenesis, and large-scale manufacturing of biological compounds such as therapeutic proteins and vaccines has also played a critical role in putting North America in the leading position. Johnson & Johnson recently collaborated with Orthocell, an Australian cell culture media company on development of a stem cell-based approach for the regeneration of tendons.
Competitive Landscape
The cell culture media market report provides both, qualitative and quantitative research of the market, as well as strategic insights along with developments that are being adopted by the key contenders. The report also offers extensive research on the key players in this market and detailed insights on the competitiveness of these players. The key business strategies such as mergers and acquisition (M&A), affiliations, collaborations, and contracts adopted by the major players are also recognized and analyzed in the report. For each company, the report recognizes their manufacturing base, research institutes, competitors, product type, application and specification, pricing, and gross margin.
Cell culture media market participants include Merck KGaA, BD Biosciences, Cell Essentials, Inc., Quality Biological, Inc., Bio-Techne Corporation (Atlanta Biologicals, Inc.), Affymetrix, Inc., SIAM Bioscience, Novozymes A/S, Thermo Fisher Scientific, Inc., ClonTech Laboratories, Inc. (Takara Bio USA, Inc.), Analytical Biological Services Inc., J R Scientific Inc., MP Biomedicals, SeraCare Life Sciences, Inc., Stemcell Technologies Inc., Lonza, GE Healthcare amongst others. Lonza entered into agreement with TxCell for manufacture of CAR-Treg cellular product, which is in development for the prevention of chronic rejection after organ transplantation.
Cell Culture Media Market Background
1. Introduction
1.1. Market Scope
1.2. Market Segmentation
1.3. Methodology
1.4. Assumptions
2. Cell Culture Media Market Snapshot
3. Executive Summary: Cell Culture Media Market
4. Qualitative Analysis: Cell Culture Media Market
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Development
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Trends in Market
5. Global Cell Culture Media Market Analysis and Forecasts, 2018
– 2026
5.1. Overview
5.1.1. Global Market Revenue (US$ Mn) and Forecasts
5.2. Global Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Reagent Type
5.2.1. Albumin (Definition, Market Penetration, Market Revenue
Expected to Increase by 2026, Compound Annual Growth Rate (CAGR) and
information on Bovine Serum Albumin, Human Serum Albumin, Recombinant Human
Serum Albumin)
5.2.1.1. Bovine Serum Albumin
5.2.1.2. Human Serum Albumin
5.2.1.3. Recombinant Human Serum Albumin
5.2.2. Hormones
5.2.2.1. Definition
5.2.2.2. Market Penetration
5.2.2.3. Market Revenue Expected to Increase by 2026
5.2.2.4. Compound Annual Growth Rate (CAGR)
5.2.3. Attachment Factors
5.2.3.1. Definition
5.2.3.2. Market Penetration
5.2.3.3. Market Revenue Expected to Increase by 2026
5.2.3.4. Compound Annual Growth Rate (CAGR)
5.2.4. Amino Acid
5.2.4.1. Definition
5.2.4.2. Market Penetration
5.2.4.3. Market Revenue Expected to Increase by 2026
5.2.4.4. Compound Annual Growth Rate (CAGR)
5.2.5. Growth factors and Cytokines (Definition, Market Penetration,
Market Revenue Expected to Increase by 2026, Compound Annual Growth Rate (CAGR)
and information on Tumor Necrosis Factors, Insulin-Like Growth Factors,
Interferons, Interleukins)
5.2.5.1. Tumor Necrosis Factors
5.2.5.2. Insulin-Like Growth Factors
5.2.5.3. Interferons
5.2.5.4. Interleukins
5.3. Key Segment for Channeling Investments
5.3.1. By Reagent Type
6. Global Cell Culture Media Market Analysis and Forecasts, 2018
– 2026
6.1. Overview
6.2. Global Market Revenue (US$ Mn) and Forecasts, By Type
6.2.1. Chemically-Defined Media
6.2.1.1. Definition
6.2.1.2. Market Penetration
6.2.1.3. Market Revenue Expected to Increase by 2026
6.2.1.4. Compound Annual Growth Rate (CAGR)
6.2.2. Classical Media
6.2.2.1. Definition
6.2.2.2. Market Penetration
6.2.2.3. Market Revenue Expected to Increase by 2026
6.2.2.4. Compound Annual Growth Rate (CAGR)
6.2.3. Lysogeny Broth
6.2.3.1. Definition
6.2.3.2. Market Penetration
6.2.3.3. Market Revenue Expected to Increase by 2026
6.2.3.4. Compound Annual Growth Rate (CAGR)
6.2.4. Protein-Free Media
6.2.4.1. Definition
6.2.4.2. Market Penetration
6.2.4.3. Market Revenue Expected to Increase by 2026
6.2.4.4. Compound Annual Growth Rate (CAGR)
6.2.5. Serum-Free Media
6.2.5.1. Definition
6.2.5.2. Market Penetration
6.2.5.3. Market Revenue Expected to Increase by 2026
6.2.5.4. Compound Annual Growth Rate (CAGR)
6.2.6. Specialty Media
6.2.6.1. Definition
6.2.6.2. Market Penetration
6.2.6.3. Market Revenue Expected to Increase by 2026
6.2.6.4. Compound Annual Growth Rate (CAGR)
6.3. Key Segment for Channeling Investments
6.3.1. By Type
7. Global Cell Culture Media Market Analysis and Forecasts, 2018
– 2026
7.1. Overview
7.2. Global Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Application
7.2.1. Biopharmaceuticals and Therapeutics
7.2.1.1. Definition
7.2.1.2. Market Penetration
7.2.1.3. Market Revenue Expected to Increase by 2026
7.2.1.4. Compound Annual Growth Rate (CAGR)
7.2.2. Biotech Research
7.2.2.1. Definition
7.2.2.2. Market Penetration
7.2.2.3. Market Revenue Expected to Increase by 2026
7.2.2.4. Compound Annual Growth Rate (CAGR)
7.2.3. Cancer
7.2.3.1. Definition
7.2.3.2. Market Penetration
7.2.3.3. Market Revenue Expected to Increase by 2026
7.2.3.4. Compound Annual Growth Rate (CAGR)
7.2.4. Drug Screening and Drug Development
7.2.4.1. Definition
7.2.4.2. Market Penetration
7.2.4.3. Market Revenue Expected to Increase by 2026
7.2.4.4. Compound Annual Growth Rate (CAGR)
7.2.5. Regenerative Medicine and Tissue Engineering
7.2.5.1. Definition
7.2.5.2. Market Penetration
7.2.5.3. Market Revenue Expected to Increase by 2026
7.2.5.4. Compound Annual Growth Rate (CAGR)
7.2.6. Stem Cell Technologies
7.2.6.1. Definition
7.2.6.2. Market Penetration
7.2.6.3. Market Revenue Expected to Increase by 2026
7.2.6.4. Compound Annual Growth Rate (CAGR)
7.3. Key Segment for Channeling Investments
7.3.1. By Application
8. Global Cell Culture Media Market Analysis and Forecasts, 2018
– 2026
8.1. Overview
8.2. Global Market Revenue (US$ Mn) and Forecasts, By End User
8.2.1. Biotechnology and Pharmaceutical Companies
8.2.1.1. Definition
8.2.1.2. Market Penetration
8.2.1.3. Market Revenue Expected to Increase by 2026
8.2.1.4. Compound Annual Growth Rate (CAGR)
8.2.2. Research Laboratories
8.2.2.1. Definition
8.2.2.2. Market Penetration
8.2.2.3. Market Revenue Expected to Increase by 2026
8.2.2.4. Compound Annual Growth Rate (CAGR)
8.2.3. Academic Institutes
8.2.3.1. Definition
8.2.3.2. Market Penetration
8.2.3.3. Market Revenue Expected to Increase by 2026
8.2.3.4. Compound Annual Growth Rate (CAGR)
8.2.4. Pathology Labs
8.2.4.1. Definition
8.2.4.2. Market Penetration
8.2.4.3. Market Revenue Expected to Increase by 2026
8.2.4.4. Compound Annual Growth Rate (CAGR)
8.3. Key Segment for Channeling Investments
8.3.1. By End User
9. North America Cell Culture Media Market Analysis and
Forecasts, 2018 – 2026
9.1. Overview
9.1.1. North America Market Revenue (US$ Mn)
9.2. North America Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Reagent Type
9.2.1. Albumin
9.2.1.1. Bovine Serum Albumin
9.2.1.2. Human Serum Albumin
9.2.1.3. Recombinant Human Serum Albumin
9.2.2. Hormones
9.2.3. Attachment Factors
9.2.4. Amino Acid
9.2.5. Growth factors and Cytokines
9.2.5.1. Tumor Necrosis Factors
9.2.5.2. Insulin-Like Growth Factors
9.2.5.3. Interferons
9.2.5.4. Interleukins
9.3. North America Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Type
9.3.1. Chemically-Defined Media
9.3.2. Classical Media
9.3.3. Lysogeny Broth
9.3.4. Protein-Free Media
9.3.5. Serum-Free Media
9.3.6. Specialty Media
9.4. North America Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Application
9.4.1. Biopharmaceuticals and Therapeutics
9.4.2. Biotech Research
9.4.3. Cancer
9.4.4. Drug Screening and Drug Development
9.4.5. Regenerative Medicine and Tissue Engineering
9.4.6. Stem Cell Technologies
9.5. North America Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By End User
9.5.1. Biotechnology and Pharmaceutical Companies
9.5.2. Research Laboratories
9.5.3. Academic Institutes
9.5.4. Pathology Labs
9.6. North America Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Country
9.6.1. U.S.
9.6.1.1. U.S. Market Revenue (US$ Mn) and Forecasts, By Reagent Type
9.6.1.1.1. Albumin
9.6.1.1.1.1. Bovine Serum Albumin
9.6.1.1.1.2. Human Serum Albumin
9.6.1.1.1.3. Recombinant Human Serum Albumin
9.6.1.1.2. Hormones
9.6.1.1.3. Attachment Factors
9.6.1.1.4. Amino Acid
9.6.1.1.5. Growth factors and Cytokines
9.6.1.1.5.1. Tumor Necrosis Factors
9.6.1.1.5.2. Insulin-Like Growth Factors
9.6.1.1.5.3. Interferons
9.6.1.1.5.4. Interleukins
9.6.1.2. U.S. Cell Culture Media Market Revenue (US$ Mn) and Forecasts,
By Type
9.6.1.2.1. Chemically-Defined Media
9.6.1.2.2. Classical Media
9.6.1.2.3. Lysogeny Broth
9.6.1.2.4. Protein-Free Media
9.6.1.2.5. Serum-Free Media
9.6.1.2.6. Specialty Media
9.6.1.3. U.S. Market Revenue (US$ Mn) and Forecasts, By Application
9.6.1.3.1. Biopharmaceuticals and Therapeutics
9.6.1.3.2. Biotech Research
9.6.1.3.3. Cancer
9.6.1.3.4. Drug Screening and Drug Development
9.6.1.3.5. Regenerative Medicine and Tissue Engineering
9.6.1.3.6. Stem Cell Technologies
9.6.1.4. U.S. Cell Culture Media Market Revenue (US$ Mn) and Forecasts,
By End User
9.6.1.4.1. Biotechnology and Pharmaceutical Companies
9.6.1.4.2. Research Laboratories
9.6.1.4.3. Academic Institutes
9.6.1.4.4. Pathology Labs
9.6.2. Rest of North America
9.6.2.1. Rest of North America Cell Culture Media Market Revenue (US$
Mn) and Forecasts, By Reagent Type
9.6.2.1.1. Albumin
9.6.2.1.1.1. Bovine Serum Albumin
9.6.2.1.1.2. Human Serum Albumin
9.6.2.1.1.3. Recombinant Human Serum Albumin
9.6.2.1.2. Hormones
9.6.2.1.3. Attachment Factors
9.6.2.1.4. Amino Acid
9.6.2.1.5. Growth factors and Cytokines
9.6.2.1.5.1. Tumor Necrosis Factors
9.6.2.1.5.2. Insulin-Like Growth Factors
9.6.2.1.5.3. Interferons
9.6.2.1.5.4. Interleukins
9.6.2.2. Rest of North America Cell Culture Media Market Revenue (US$
Mn) and Forecasts, By Type
9.6.2.2.1. Chemically-Defined Media
9.6.2.2.2. Classical Media
9.6.2.2.3. Lysogeny Broth
9.6.2.2.4. Protein-Free Media
9.6.2.2.5. Serum-Free Media
9.6.2.2.6. Specialty Media
9.6.2.3. Rest of North America Market Revenue (US$ Mn) and Forecasts,
By Application
9.6.2.3.1. Biopharmaceuticals and Therapeutics
9.6.2.3.2. Biotech Research
9.6.2.3.3. Cancer
9.6.2.3.4. Drug Screening and Drug Development
9.6.2.3.5. Regenerative Medicine and Tissue Engineering
9.6.2.3.6. Stem Cell Technologies
9.6.2.4. Rest of North America Cell Culture Media Market Revenue (US$
Mn) and Forecasts, By End User
9.6.2.4.1. Biotechnology and Pharmaceutical Companies
9.6.2.4.2. Research Laboratories
9.6.2.4.3. Academic Institutes
9.6.2.4.4. Pathology Labs
9.7. Key Segment for Channeling Investments
9.7.1. By Country
9.7.2. By Reagent Type
9.7.3. By Type
9.7.4. By Application
9.7.5. By End User
10. Europe Cell Culture Media Market Analysis and Forecasts, 2018
– 2026
10.1. Overview
10.1.1. Europe Market Revenue (US$ Mn)
10.2. Europe Market Revenue (US$ Mn) and Forecasts, By Reagent Type
10.2.1. Albumin
10.2.1.1. Bovine Serum Albumin
10.2.1.2. Human Serum Albumin
10.2.1.3. Recombinant Human Serum Albumin
10.2.2. Hormones
10.2.3. Attachment Factors
10.2.4. Amino Acid
10.2.5. Growth factors and Cytokines
10.2.5.1. Tumor Necrosis Factors
10.2.5.2. Insulin-Like Growth Factors
10.2.5.3. Interferons
10.2.5.4. Interleukins
10.3. Europe Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Type
10.3.1. Chemically-Defined Media
10.3.2. Classical Media
10.3.3. Lysogeny Broth
10.3.4. Protein-Free Media
10.3.5. Serum-Free Media
10.3.6. Specialty Media
10.4. Europe Market Revenue (US$ Mn) and Forecasts, By Application
10.4.1. Biopharmaceuticals and Therapeutics
10.4.2. Biotech Research
10.4.3. Cancer
10.4.4. Drug Screening and Drug Development
10.4.5. Regenerative Medicine and Tissue Engineering
10.4.6. Stem Cell Technologies
10.5. Europe Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By End User
10.5.1. Biotechnology and Pharmaceutical Companies
10.5.2. Research Laboratories
10.5.3. Academic Institutes
10.5.4. Pathology Labs
10.6. Europe Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Country
10.6.1. France
10.6.1.1. France Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Reagent Type
10.6.1.1.1. Albumin
10.6.1.1.1.1. Bovine Serum Albumin
10.6.1.1.1.2. Human Serum Albumin
10.6.1.1.1.3. Recombinant Human Serum Albumin
10.6.1.1.2. Hormones
10.6.1.1.3. Attachment Factors
10.6.1.1.4. Amino Acid
10.6.1.1.5. Growth factors and Cytokines
10.6.1.1.5.1.
Tumor Necrosis Factors
10.6.1.1.5.2.
Insulin-Like Growth
Factors
10.6.1.1.5.3.
Interferons
10.6.1.1.5.4.
Interleukins
10.6.1.2. France Market Revenue (US$ Mn) and Forecasts, By Type
10.6.1.2.1. Chemically-Defined Media
10.6.1.2.2. Classical Media
10.6.1.2.3. Lysogeny Broth
10.6.1.2.4. Protein-Free Media
10.6.1.2.5. Serum-Free Media
10.6.1.2.6. Specialty Media
10.6.1.3. France Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Application
10.6.1.3.1. Biopharmaceuticals and Therapeutics
10.6.1.3.2. Biotech Research
10.6.1.3.3. Cancer
10.6.1.3.4. Drug Screening and Drug Development
10.6.1.3.5. Regenerative Medicine and Tissue Engineering
10.6.1.3.6. Stem Cell Technologies
10.6.1.4. France Market Revenue (US$ Mn) and Forecasts, By End User
10.6.1.4.1. Biotechnology and Pharmaceutical Companies
10.6.1.4.2. Research Laboratories
10.6.1.4.3. Academic Institutes
10.6.1.4.4. Pathology Labs
10.6.2. The UK
10.6.2.1. The UK Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Reagent Type
10.6.2.1.1. Albumin
10.6.2.1.1.1. Bovine Serum Albumin
10.6.2.1.1.2. Human Serum Albumin
10.6.2.1.1.3. Recombinant Human Serum Albumin
10.6.2.1.2. Hormones
10.6.2.1.3. Attachment Factors
10.6.2.1.4. Amino Acid
10.6.2.1.5. Growth factors and Cytokines
10.6.2.1.5.1.
Tumor Necrosis Factors
10.6.2.1.5.2.
Insulin-Like Growth
Factors
10.6.2.1.5.3.
Interferons
10.6.2.1.5.4.
Interleukins
10.6.2.2. The UK Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Type
10.6.2.2.1. Chemically-Defined Media
10.6.2.2.2. Classical Media
10.6.2.2.3. Lysogeny Broth
10.6.2.2.4. Protein-Free Media
10.6.2.2.5. Serum-Free Media
10.6.2.2.6. Specialty Media
10.6.2.3. The UK Market Revenue (US$ Mn) and Forecasts, By Application
10.6.2.3.1. Biopharmaceuticals and Therapeutics
10.6.2.3.2. Biotech Research
10.6.2.3.3. Cancer
10.6.2.3.4. Drug Screening and Drug Development
10.6.2.3.5. Regenerative Medicine and Tissue Engineering
10.6.2.3.6. Stem Cell Technologies
10.6.2.4. The UK Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By End User
10.6.2.4.1. Biotechnology and Pharmaceutical Companies
10.6.2.4.2. Research Laboratories
10.6.2.4.3. Academic Institutes
10.6.2.4.4. Pathology Labs
10.6.3. Spain
10.6.3.1. Spain Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Reagent Type
10.6.3.1.1. Albumin
10.6.3.1.1.1.
Bovine Serum Albumin
10.6.3.1.1.2.
Human Serum Albumin
10.6.3.1.1.3.
Recombinant Human Serum
Albumin
10.6.3.1.2. Hormones
10.6.3.1.3. Attachment Factors
10.6.3.1.4. Amino Acid
10.6.3.1.5. Growth factors and Cytokines
10.6.3.1.5.1.
Tumor Necrosis Factors
10.6.3.1.5.2.
Insulin-Like Growth
Factors
10.6.3.1.5.3.
Interferons
10.6.3.1.5.4. Interleukins
10.6.3.2. Spain Market Revenue (US$ Mn) and Forecasts, By Type
10.6.3.2.1. Chemically-Defined Media
10.6.3.2.2. Classical Media
10.6.3.2.3. Lysogeny Broth
10.6.3.2.4. Protein-Free Media
10.6.3.2.5. Serum-Free Media
10.6.3.2.6. Specialty Media
10.6.3.3. Spain Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Application
10.6.3.3.1. Biopharmaceuticals and Therapeutics
10.6.3.3.2. Biotech Research
10.6.3.3.3. Cancer
10.6.3.3.4. Drug Screening and Drug Development
10.6.3.3.5. Regenerative Medicine and Tissue Engineering
10.6.3.3.6. Stem Cell Technologies
10.6.3.4. Spain Market Revenue (US$ Mn) and Forecasts, By End User
10.6.3.4.1. Biotechnology and Pharmaceutical Companies
10.6.3.4.2. Research Laboratories
10.6.3.4.3. Academic Institutes
10.6.3.4.4. Pathology Labs
10.6.4. Germany
10.6.4.1. Germany Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Reagent Type
10.6.4.1.1. Albumin
10.6.4.1.1.1.
Bovine Serum Albumin
10.6.4.1.1.2.
Human Serum Albumin
10.6.4.1.1.3.
Recombinant Human Serum
Albumin
10.6.4.1.2. Hormones
10.6.4.1.3. Attachment Factors
10.6.4.1.4. Amino Acid
10.6.4.1.5. Growth factors and Cytokines
10.6.4.1.5.1.
Tumor Necrosis Factors
10.6.4.1.5.2.
Insulin-Like Growth
Factors
10.6.4.1.5.3.
Interferons
10.6.4.1.5.4.
Interleukins
10.6.4.2. Germany Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Type
10.6.4.2.1. Chemically-Defined Media
10.6.4.2.2. Classical Media
10.6.4.2.3. Lysogeny Broth
10.6.4.2.4. Protein-Free Media
10.6.4.2.5. Serum-Free Media
10.6.4.2.6. Specialty Media
10.6.4.3. Germany Market Revenue (US$ Mn) and Forecasts, By Application
10.6.4.3.1. Biopharmaceuticals and Therapeutics
10.6.4.3.2. Biotech Research
10.6.4.3.3. Cancer
10.6.4.3.4. Drug Screening and Drug Development
10.6.4.3.5. Regenerative Medicine and Tissue Engineering
10.6.4.3.6. Stem Cell Technologies
10.6.4.4. Germany Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By End User
10.6.4.4.1. Biotechnology and Pharmaceutical Companies
10.6.4.4.2. Research Laboratories
10.6.4.4.3. Academic Institutes
10.6.4.4.4. Pathology Labs
10.6.5. Italy
10.6.5.1. Italy Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Reagent Type
10.6.5.1.1. Albumin
10.6.5.1.1.1.
Bovine Serum Albumin
10.6.5.1.1.2.
Human Serum Albumin
10.6.5.1.1.3.
Recombinant Human Serum
Albumin
10.6.5.1.2. Hormones
10.6.5.1.3. Attachment Factors
10.6.5.1.4. Amino Acid
10.6.5.1.5. Growth factors and Cytokines
10.6.5.1.5.1.
Tumor Necrosis Factors
10.6.5.1.5.2.
Insulin-Like Growth
Factors
10.6.5.1.5.3.
Interferons
10.6.5.1.5.4. Interleukins
10.6.5.2. Italy Market Revenue (US$ Mn) and Forecasts, By Type
10.6.5.2.1. Chemically-Defined Media
10.6.5.2.2. Classical Media
10.6.5.2.3. Lysogeny Broth
10.6.5.2.4. Protein-Free Media
10.6.5.2.5. Serum-Free Media
10.6.5.2.6. Specialty Media
10.6.5.3. Italy Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Application
10.6.5.3.1. Biopharmaceuticals and Therapeutics
10.6.5.3.2. Biotech Research
10.6.5.3.3. Cancer
10.6.5.3.4. Drug Screening and Drug Development
10.6.5.3.5. Regenerative Medicine and Tissue Engineering
10.6.5.3.6. Stem Cell Technologies
10.6.5.4. Italy Market Revenue (US$ Mn) and Forecasts, By End User
10.6.5.4.1. Biotechnology and Pharmaceutical Companies
10.6.5.4.2. Research Laboratories
10.6.5.4.3. Academic Institutes
10.6.5.4.4. Pathology Labs
10.6.6. Rest of Europe
10.6.6.1. Rest of Europe Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Reagent Type
10.6.6.1.1. Albumin
10.6.6.1.1.1.
Bovine Serum Albumin
10.6.6.1.1.2.
Human Serum Albumin
10.6.6.1.1.3.
Recombinant Human Serum
Albumin
10.6.6.1.2. Hormones
10.6.6.1.3. Attachment Factors
10.6.6.1.4. Amino Acid
10.6.6.1.5. Growth factors and Cytokines
10.6.6.1.5.1.
Tumor Necrosis Factors
10.6.6.1.5.2.
Insulin-Like Growth
Factors
10.6.6.1.5.3.
Interferons
10.6.6.1.5.4.
Interleukins
10.6.6.2. Rest of Europe Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Type
10.6.6.2.1. Chemically-Defined Media
10.6.6.2.2. Classical Media
10.6.6.2.3. Lysogeny Broth
10.6.6.2.4. Protein-Free Media
10.6.6.2.5. Serum-Free Media
10.6.6.2.6. Specialty Media
10.6.6.3. Rest of Europe Market Revenue (US$ Mn) and Forecasts, By Application
10.6.6.3.1. Biopharmaceuticals and Therapeutics
10.6.6.3.2. Biotech Research
10.6.6.3.3. Cancer
10.6.6.3.4. Drug Screening and Drug Development
10.6.6.3.5. Regenerative Medicine and Tissue Engineering
10.6.6.3.6. Stem Cell Technologies
10.6.6.4. Rest of Europe Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By End User
10.6.6.4.1. Biotechnology and Pharmaceutical Companies
10.6.6.4.2. Research Laboratories
10.6.6.4.3. Academic Institutes
10.6.6.4.4. Pathology Labs
10.7. Key Segment for Channeling Investments
10.7.1. By Country
10.7.2. By Reagent Type
10.7.3. By Type
10.7.4. By Application
10.7.5. By End User
11. Asia Pacific Cell Culture Media Market Analysis and
Forecasts, 2018 – 2026
11.1. Overview
11.1.1. Asia Pacific Market Revenue (US$ Mn)
11.2. Asia Pacific Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Reagent Type
11.2.1. Albumin
11.2.1.1. Bovine Serum Albumin
11.2.1.2. Human Serum Albumin
11.2.1.3. Recombinant Human Serum Albumin
11.2.2. Hormones
11.2.3. Attachment Factors
11.2.4. Amino Acid
11.2.5. Growth factors and Cytokines
11.2.5.1. Tumor Necrosis Factors
11.2.5.2. Insulin-Like Growth Factors
11.2.5.3. Interferons
11.2.5.4. Interleukins
11.3. Asia Pacific Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Type
11.3.1. Chemically-Defined Media
11.3.2. Classical Media
11.3.3. Lysogeny Broth
11.3.4. Protein-Free Media
11.3.5. Serum-Free Media
11.3.6. Specialty Media
11.4. Asia Pacific Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Application
11.4.1. Biopharmaceuticals and Therapeutics
11.4.2. Biotech Research
11.4.3. Cancer
11.4.4. Drug Screening and Drug Development
11.4.5. Regenerative Medicine and Tissue Engineering
11.4.6. Stem Cell Technologies
11.5. Asia Pacific Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By End User
11.5.1. Biotechnology and Pharmaceutical Companies
11.5.2. Research Laboratories
11.5.3. Academic Institutes
11.5.4. Pathology Labs
11.6. Asia Pacific Market Revenue (US$ Mn) and Forecasts, By Country
11.6.1. China
11.6.1.1. China Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Reagent Type
11.6.1.1.1. Albumin
11.6.1.1.1.1.
Bovine Serum Albumin
11.6.1.1.1.2.
Human Serum Albumin
11.6.1.1.1.3.
Recombinant Human Serum
Albumin
11.6.1.1.2. Hormones
11.6.1.1.3. Attachment Factors
11.6.1.1.4. Amino Acid
11.6.1.1.5. Growth factors and Cytokines
11.6.1.1.5.1.
Tumor Necrosis Factors
11.6.1.1.5.2.
Insulin-Like Growth
Factors
11.6.1.1.5.3.
Interferons
11.6.1.1.5.4. Interleukins
11.6.1.2. China Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Type
11.6.1.2.1. Chemically-Defined Media
11.6.1.2.2. Classical Media
11.6.1.2.3. Lysogeny Broth
11.6.1.2.4. Protein-Free Media
11.6.1.2.5. Serum-Free Media
11.6.1.2.6. Specialty Media
11.6.1.3. China Market Revenue (US$ Mn) and Forecasts, By Application
11.6.1.3.1. Biopharmaceuticals and Therapeutics
11.6.1.3.2. Biotech Research
11.6.1.3.3. Cancer
11.6.1.3.4. Drug Screening and Drug Development
11.6.1.3.5. Regenerative Medicine and Tissue Engineering
11.6.1.3.6. Stem Cell Technologies
11.6.1.4. China Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By End User
11.6.1.4.1. Biotechnology and Pharmaceutical Companies
11.6.1.4.2. Research Laboratories
11.6.1.4.3. Academic Institutes
11.6.1.4.4. Pathology Labs
11.6.2. Japan
11.6.2.1. Japan Cell Culture Media Market Revenue (US$ Mn) and Forecasts,
By Reagent Type
11.6.2.1.1. Albumin
11.6.2.1.1.1.
Bovine Serum Albumin
11.6.2.1.1.2.
Human Serum Albumin
11.6.2.1.1.3.
Recombinant Human Serum
Albumin
11.6.2.1.2. Hormones
11.6.2.1.3. Attachment Factors
11.6.2.1.4. Amino Acid
11.6.2.1.5. Growth factors and Cytokines
11.6.2.1.5.1.
Tumor Necrosis Factors
11.6.2.1.5.2.
Insulin-Like Growth
Factors
11.6.2.1.5.3.
Interferons
11.6.2.1.5.4.
Interleukins
11.6.2.2. Japan Market Revenue (US$ Mn) and Forecasts, By Type
11.6.2.2.1. Chemically-Defined Media
11.6.2.2.2. Classical Media
11.6.2.2.3. Lysogeny Broth
11.6.2.2.4. Protein-Free Media
11.6.2.2.5. Serum-Free Media
11.6.2.2.6. Specialty Media
11.6.2.3. Japan Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Application
11.6.2.3.1. Biopharmaceuticals and Therapeutics
11.6.2.3.2. Biotech Research
11.6.2.3.3. Cancer
11.6.2.3.4. Drug Screening and Drug Development
11.6.2.3.5. Regenerative Medicine and Tissue Engineering
11.6.2.3.6. Stem Cell Technologies
11.6.2.4. Japan Market Revenue (US$ Mn) and Forecasts, By End User
11.6.2.4.1. Biotechnology and Pharmaceutical Companies
11.6.2.4.2. Research Laboratories
11.6.2.4.3. Academic Institutes
11.6.2.4.4. Pathology Labs
11.6.3. India
11.6.3.1. India Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Reagent Type
11.6.3.1.1. Albumin
11.6.3.1.1.1.
Bovine Serum Albumin
11.6.3.1.1.2.
Human Serum Albumin
11.6.3.1.1.3.
Recombinant Human Serum
Albumin
11.6.3.1.2. Hormones
11.6.3.1.3. Attachment Factors
11.6.3.1.4. Amino Acid
11.6.3.1.5. Growth factors and Cytokines
11.6.3.1.5.1.
Tumor Necrosis Factors
11.6.3.1.5.2.
Insulin-Like Growth
Factors
11.6.3.1.5.3.
Interferons
11.6.3.1.5.4.
Interleukins
11.6.3.2. India Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Type
11.6.3.2.1. Chemically-Defined Media
11.6.3.2.2. Classical Media
11.6.3.2.3. Lysogeny Broth
11.6.3.2.4. Protein-Free Media
11.6.3.2.5. Serum-Free Media
11.6.3.2.6. Specialty Media
11.6.3.3. India Market Revenue (US$ Mn) and Forecasts, By Application
11.6.3.3.1. Biopharmaceuticals and Therapeutics
11.6.3.3.2. Biotech Research
11.6.3.3.3. Cancer
11.6.3.3.4. Drug Screening and Drug Development
11.6.3.3.5. Regenerative Medicine and Tissue Engineering
11.6.3.3.6. Stem Cell Technologies
11.6.3.4. India Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By End User
11.6.3.4.1. Biotechnology and Pharmaceutical Companies
11.6.3.4.2. Research Laboratories
11.6.3.4.3. Academic Institutes
11.6.3.4.4. Pathology Labs
11.6.4. Southeast Asia
11.6.4.1. Southeast Asia Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Reagent Type
11.6.4.1.1. Albumin
11.6.4.1.1.1.
Bovine Serum Albumin
11.6.4.1.1.2.
Human Serum Albumin
11.6.4.1.1.3.
Recombinant Human Serum
Albumin
11.6.4.1.2. Hormones
11.6.4.1.3. Attachment Factors
11.6.4.1.4. Amino Acid
11.6.4.1.5. Growth factors and Cytokines
11.6.4.1.5.1.
Tumor Necrosis Factors
11.6.4.1.5.2.
Insulin-Like Growth
Factors
11.6.4.1.5.3.
Interferons
11.6.4.1.5.4.
Interleukins
11.6.4.2. Southeast Asia Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Type
11.6.4.2.1. Chemically-Defined Media
11.6.4.2.2. Classical Media
11.6.4.2.3. Lysogeny Broth
11.6.4.2.4. Protein-Free Media
11.6.4.2.5. Serum-Free Media
11.6.4.2.6. Specialty Media
11.6.4.3. Southeast Asia Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Application
11.6.4.3.1. Biopharmaceuticals and Therapeutics
11.6.4.3.2. Biotech Research
11.6.4.3.3. Cancer
11.6.4.3.4. Drug Screening and Drug Development
11.6.4.3.5. Regenerative Medicine and Tissue Engineering
11.6.4.3.6. Stem Cell Technologies
11.6.4.4. Southeast Asia Market Revenue (US$ Mn) and Forecasts, By End
User
11.6.4.4.1. Biotechnology and Pharmaceutical Companies
11.6.4.4.2. Research Laboratories
11.6.4.4.3. Academic Institutes
11.6.4.4.4. Pathology Labs
11.6.5. Rest of Asia Pacific
11.6.5.1. Rest of Asia Pacific Cell Culture Media Market Revenue (US$
Mn) and Forecasts, By Reagent Type
11.6.5.1.1. Albumin
11.6.5.1.1.1.
Bovine Serum Albumin
11.6.5.1.1.2.
Human Serum Albumin
11.6.5.1.1.3.
Recombinant Human Serum
Albumin
11.6.5.1.2. Hormones
11.6.5.1.3. Attachment Factors
11.6.5.1.4. Amino Acid
11.6.5.1.5. Growth factors and Cytokines
11.6.5.1.5.1.
Tumor Necrosis Factors
11.6.5.1.5.2.
Insulin-Like Growth
Factors
11.6.5.1.5.3.
Interferons
11.6.5.1.5.4.
Interleukins
11.6.5.2. Rest of Asia Pacific Cell Culture Media Market Revenue (US$
Mn) and Forecasts, By Type
11.6.5.2.1. Chemically-Defined Media
11.6.5.2.2. Classical Media
11.6.5.2.3. Lysogeny Broth
11.6.5.2.4. Protein-Free Media
11.6.5.2.5. Serum-Free Media
11.6.5.2.6. Specialty Media
11.6.5.3. Rest of Asia Pacific Cell Culture Media Market Revenue (US$
Mn) and Forecasts, By Application
11.6.5.3.1. Biopharmaceuticals and Therapeutics
11.6.5.3.2. Biotech Research
11.6.5.3.3. Cancer
11.6.5.3.4. Drug Screening and Drug Development
11.6.5.3.5. Regenerative Medicine and Tissue Engineering
11.6.5.3.6. Stem Cell Technologies
11.6.5.4. Rest of Asia Pacific Cell Culture Media Market Revenue (US$
Mn) and Forecasts, By End User
11.6.5.4.1. Biotechnology and Pharmaceutical Companies
11.6.5.4.2. Research Laboratories
11.6.5.4.3. Academic Institutes
11.6.5.4.4. Pathology Labs
11.7. Key Segment for Channeling Investments
11.7.1. By Country
11.7.2. By Reagent Type
11.7.3. By Type
11.7.4. By Application
11.7.5. By End User
12. Middle East and Africa Cell Culture Media Market Analysis and
Forecasts, 2018 – 2026
12.1. Overview
12.1.1. Middle East and Africa Market Revenue (US$ Mn)
12.2. Middle East and Africa Cell Culture Media Market Revenue (US$
Mn) and Forecasts, By Reagent Type
12.2.1. Albumin
12.2.1.1. Bovine Serum Albumin
12.2.1.2. Human Serum Albumin
12.2.1.3. Recombinant Human Serum Albumin
12.2.2. Hormones
12.2.3. Attachment Factors
12.2.4. Amino Acid
12.2.5. Growth factors and Cytokines
12.2.5.1. Tumor Necrosis Factors
12.2.5.2. Insulin-Like Growth Factors
12.2.5.3. Interferons
12.2.5.4. Interleukins
12.3. Middle East and Africa Cell Culture Media Market Revenue (US$
Mn) and Forecasts, By Type
12.3.1. Chemically-Defined Media
12.3.2. Classical Media
12.3.3. Lysogeny Broth
12.3.4. Protein-Free Media
12.3.5. Serum-Free Media
12.3.6. Specialty Media
12.4. Middle East and Africa Market Revenue (US$ Mn) and Forecasts,
By Application
12.4.1. Biopharmaceuticals and Therapeutics
12.4.2. Biotech Research
12.4.3. Cancer
12.4.4. Drug Screening and Drug Development
12.4.5. Regenerative Medicine and Tissue Engineering
12.4.6. Stem Cell Technologies
12.5. Middle East and Africa Cell Culture Media Market Revenue (US$
Mn) and Forecasts, By End User
12.5.1. Biotechnology and Pharmaceutical Companies
12.5.2. Research Laboratories
12.5.3. Academic Institutes
12.5.4. Pathology Labs
12.6. Middle East and Africa Cell Culture Media Market Revenue (US$
Mn) and Forecasts, By Country
12.6.1. GCC Countries
12.6.1.1. GCC Countries Market Revenue (US$ Mn) and Forecasts, By
Reagent Type
12.6.1.1.1. Albumin
12.6.1.1.1.1.
Bovine Serum Albumin
12.6.1.1.1.2.
Human Serum Albumin
12.6.1.1.1.3.
Recombinant Human Serum
Albumin
12.6.1.1.2. Hormones
12.6.1.1.3. Attachment Factors
12.6.1.1.4. Amino Acid
12.6.1.1.5. Growth factors and Cytokines
12.6.1.1.5.1.
Tumor Necrosis Factors
12.6.1.1.5.2.
Insulin-Like Growth
Factors
12.6.1.1.5.3.
Interferons
12.6.1.1.5.4.
Interleukins
12.6.1.2. GCC Countries Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Type
12.6.1.2.1. Chemically-Defined Media
12.6.1.2.2. Classical Media
12.6.1.2.3. Lysogeny Broth
12.6.1.2.4. Protein-Free Media
12.6.1.2.5. Serum-Free Media
12.6.1.2.6. Specialty Media
12.6.1.3. GCC Countries Market Revenue (US$ Mn) and Forecasts, By
Application
12.6.1.3.1. Biopharmaceuticals and Therapeutics
12.6.1.3.2. Biotech Research
12.6.1.3.3. Cancer
12.6.1.3.4. Drug Screening and Drug Development
12.6.1.3.5. Regenerative Medicine and Tissue Engineering
12.6.1.3.6. Stem Cell Technologies
12.6.1.4. GCC Countries Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By End User
12.6.1.4.1. Biotechnology and Pharmaceutical Companies
12.6.1.4.2. Research Laboratories
12.6.1.4.3. Academic Institutes
12.6.1.4.4. Pathology Labs
12.6.2. Southern Africa
12.6.2.1. Southern Africa Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Reagent Type
12.6.2.1.1. Albumin
12.6.2.1.1.1.
Bovine Serum Albumin
12.6.2.1.1.2.
Human Serum Albumin
12.6.2.1.1.3.
Recombinant Human Serum
Albumin
12.6.2.1.2. Hormones
12.6.2.1.3. Attachment Factors
12.6.2.1.4. Amino Acid
12.6.2.1.5. Growth factors and Cytokines
12.6.2.1.5.1.
Tumor Necrosis Factors
12.6.2.1.5.2.
Insulin-Like Growth
Factors
12.6.2.1.5.3.
Interferons
12.6.2.1.5.4.
Interleukins
12.6.2.2. Southern Africa Market Revenue (US$ Mn) and Forecasts, By Type
12.6.2.2.1. Chemically-Defined Media
12.6.2.2.2. Classical Media
12.6.2.2.3. Lysogeny Broth
12.6.2.2.4. Protein-Free Media
12.6.2.2.5. Serum-Free Media
12.6.2.2.6. Specialty Media
12.6.2.3. Southern Africa Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Application
12.6.2.3.1. Biopharmaceuticals and Therapeutics
12.6.2.3.2. Biotech Research
12.6.2.3.3. Cancer
12.6.2.3.4. Drug Screening and Drug Development
12.6.2.3.5. Regenerative Medicine and Tissue Engineering
12.6.2.3.6. Stem Cell Technologies
12.6.2.4. Southern Africa Market Revenue (US$ Mn) and Forecasts, By End
User
12.6.2.4.1. Biotechnology and Pharmaceutical Companies
12.6.2.4.2. Research Laboratories
12.6.2.4.3. Academic Institutes
12.6.2.4.4. Pathology Labs
12.6.3. Rest of MEA
12.6.3.1. Rest of MEA Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Reagent Type
12.6.3.1.1. Albumin
12.6.3.1.1.1.
Bovine Serum Albumin
12.6.3.1.1.2.
Human Serum Albumin
12.6.3.1.1.3.
Recombinant Human Serum
Albumin
12.6.3.1.2. Hormones
12.6.3.1.3. Attachment Factors
12.6.3.1.4. Amino Acid
12.6.3.1.5. Growth factors and Cytokines
12.6.3.1.5.1.
Tumor Necrosis Factors
12.6.3.1.5.2.
Insulin-Like Growth
Factors
12.6.3.1.5.3.
Interferons
12.6.3.1.5.4. Interleukins
12.6.3.2. Rest of MEA Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Type
12.6.3.2.1. Chemically-Defined Media
12.6.3.2.2. Classical Media
12.6.3.2.3. Lysogeny Broth
12.6.3.2.4. Protein-Free Media
12.6.3.2.5. Serum-Free Media
12.6.3.2.6. Specialty Media
12.6.3.3. Rest of MEA Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Application
12.6.3.3.1. Biopharmaceuticals and Therapeutics
12.6.3.3.2. Biotech Research
12.6.3.3.3. Cancer
12.6.3.3.4. Drug Screening and Drug Development
12.6.3.3.5. Regenerative Medicine and Tissue Engineering
12.6.3.3.6. Stem Cell Technologies
12.6.3.4. Rest of MEA Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By End User
12.6.3.4.1. Biotechnology and Pharmaceutical Companies
12.6.3.4.2. Research Laboratories
12.6.3.4.3. Academic Institutes
12.6.3.4.4. Pathology Labs
12.7. Key Segment for Channeling Investments
12.7.1. By Country
12.7.2. By Reagent Type
12.7.3. By Type
12.7.4. By Application
12.7.5. By End User
13. Latin America Cell Culture Media Market Analysis and
Forecasts, 2018 – 2026
13.1. Overview
13.1.1. Latin America Market Revenue (US$ Mn)
13.2. Latin America Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Reagent Type
13.2.1. Albumin
13.2.1.1. Bovine Serum Albumin
13.2.1.2. Human Serum Albumin
13.2.1.3. Recombinant Human Serum Albumin
13.2.2. Hormones
13.2.3. Attachment Factors
13.2.4. Amino Acid
13.2.5. Growth factors and Cytokines
13.2.5.1. Tumor Necrosis Factors
13.2.5.2. Insulin-Like Growth Factors
13.2.5.3. Interferons
13.2.5.4. Interleukins
13.3. Latin America Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Type
13.3.1. Chemically-Defined Media
13.3.2. Classical Media
13.3.3. Lysogeny Broth
13.3.4. Protein-Free Media
13.3.5. Serum-Free Media
13.3.6. Specialty Media
13.4. Latin America Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Application
13.4.1. Biopharmaceuticals and Therapeutics
13.4.2. Biotech Research
13.4.3. Cancer
13.4.4. Drug Screening and Drug Development
13.4.5. Regenerative Medicine and Tissue Engineering
13.4.6. Stem Cell Technologies
13.5. Latin America Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By End User
13.5.1. Biotechnology and Pharmaceutical Companies
13.5.2. Research Laboratories
13.5.3. Academic Institutes
13.5.4. Pathology Labs
13.6. Latin America Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Country
13.6.1. Brazil
13.6.1.1. Brazil Market Revenue (US$ Mn) and Forecasts, By Reagent Type
13.6.1.1.1. Albumin
13.6.1.1.1.1.
Bovine Serum Albumin
13.6.1.1.1.2.
Human Serum Albumin
13.6.1.1.1.3.
Recombinant Human Serum
Albumin
13.6.1.1.2. Hormones
13.6.1.1.3. Attachment Factors
13.6.1.1.4. Amino Acid
13.6.1.1.5. Growth factors and Cytokines
13.6.1.1.5.1.
Tumor Necrosis Factors
13.6.1.1.5.2.
Insulin-Like Growth Factors
13.6.1.1.5.3.
Interferons
13.6.1.1.5.4. Interleukins
13.6.1.2. Brazil Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Type
13.6.1.2.1. Chemically-Defined Media
13.6.1.2.2. Classical Media
13.6.1.2.3. Lysogeny Broth
13.6.1.2.4. Protein-Free Media
13.6.1.2.5. Serum-Free Media
13.6.1.2.6. Specialty Media
13.6.1.3. Brazil Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Application
13.6.1.3.1. Biopharmaceuticals and Therapeutics
13.6.1.3.2. Biotech Research
13.6.1.3.3. Cancer
13.6.1.3.4. Drug Screening and Drug Development
13.6.1.3.5. Regenerative Medicine and Tissue Engineering
13.6.1.3.6. Stem Cell Technologies
13.6.1.4. Brazil Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By End User
13.6.1.4.1. Biotechnology and Pharmaceutical Companies
13.6.1.4.2. Research Laboratories
13.6.1.4.3. Academic Institutes
13.6.1.4.4. Pathology Labs
13.6.2. Rest of Latin America
13.6.2.1. Rest of Latin America Cell Culture Media Market Revenue (US$
Mn) and Forecasts, By Reagent Type
13.6.2.1.1. Albumin
13.6.2.1.1.1.
Bovine Serum Albumin
13.6.2.1.1.2.
Human Serum Albumin
13.6.2.1.1.3.
Recombinant Human Serum
Albumin
13.6.2.1.2. Hormones
13.6.2.1.3. Attachment Factors
13.6.2.1.4. Amino Acid
13.6.2.1.5. Growth factors and Cytokines
13.6.2.1.5.1.
Tumor Necrosis Factors
13.6.2.1.5.2.
Insulin-Like Growth
Factors
13.6.2.1.5.3.
Interferons
13.6.2.1.5.4.
Interleukins
13.6.2.2. Rest of Latin America Cell Culture Media Market Revenue (US$
Mn) and Forecasts, By Type
13.6.2.2.1. Chemically-Defined Media
13.6.2.2.2. Classical Media
13.6.2.2.3. Lysogeny Broth
13.6.2.2.4. Protein-Free Media
13.6.2.2.5. Serum-Free Media
13.6.2.2.6. Specialty Media
13.6.2.3. Rest of Latin America Market Revenue (US$ Mn) and Forecasts,
By Application
13.6.2.3.1. Biopharmaceuticals and Therapeutics
13.6.2.3.2. Biotech Research
13.6.2.3.3. Cancer
13.6.2.3.4. Drug Screening and Drug Development
13.6.2.3.5. Regenerative Medicine and Tissue Engineering
13.6.2.3.6. Stem Cell Technologies
13.6.2.4. Rest of Latin America Cell Culture Media Market Revenue (US$ Mn)
and Forecasts, By End User
13.6.2.4.1. Biotechnology and Pharmaceutical Companies
13.6.2.4.2. Research Laboratories
13.6.2.4.3. Academic Institutes
13.6.2.4.4. Pathology Labs
13.7. Key Segment for Channeling Investments
13.7.1. By Country
13.7.2. By Reagent Type
13.7.3. By Type
13.7.4. By Application
13.7.5. By End User
14. Competitive Benchmarking
14.1. Player Positioning Analysis
14.2. Global Presence and Growth Strategies
15. Player Profiles
15.1. Affymetrix, Inc.
15.1.1. Company Details
15.1.2. Company Overview
15.1.3. Product Offerings
15.1.4. Key Developments
15.1.5. Financial Analysis
15.1.6. SWOT Analysis
15.1.7. Business Strategies
15.2. Analytical Biological Services Inc.
15.2.1. Company Details
15.2.2. Company Overview
15.2.3. Product Offerings
15.2.4. Key Developments
15.2.5. Financial Analysis
15.2.6. SWOT Analysis
15.2.7. Business Strategies
15.3. BD Biosciences
15.3.1. Company Details
15.3.2. Company Overview
15.3.3. Product Offerings
15.3.4. Key Developments
15.3.5. Financial Analysis
15.3.6. SWOT Analysis
15.3.7. Business Strategies
15.4. Bio-Techne Corporation
15.4.1. Company Details
15.4.2. Company Overview
15.4.3. Product Offerings
15.4.4. Key Developments
15.4.5. Financial Analysis
15.4.6. SWOT Analysis
15.4.7. Business Strategies
15.5. Cell Essentials, Inc.
15.5.1. Company Details
15.5.2. Company Overview
15.5.3. Product Offerings
15.5.4. Key Developments
15.5.5. Financial Analysis
15.5.6. SWOT Analysis
15.5.7. Business Strategies
15.6. ClonTech Laboratories, Inc.
15.6.1. Company Details
15.6.2. Company Overview
15.6.3. Product Offerings
15.6.4. Key Developments
15.6.5. Financial Analysis
15.6.6. SWOT Analysis
15.6.7. Business Strategies
15.7. GE Healthcare
15.7.1. Company Details
15.7.2. Company Overview
15.7.3. Product Offerings
15.7.4. Key Developments
15.7.5. Financial Analysis
15.7.6. SWOT Analysis
15.7.7. Business Strategies
15.8. J R Scientific Inc.
15.8.1. Company Details
15.8.2. Company Overview
15.8.3. Product Offerings
15.8.4. Key Developments
15.8.5. Financial Analysis
15.8.6. SWOT Analysis
15.8.7. Business Strategies
15.9. Johnson & Johnson
15.9.1. Company Details
15.9.2. Company Overview
15.9.3. Product Offerings
15.9.4. Key Developments
15.9.5. Financial Analysis
15.9.6. SWOT Analysis
15.9.7. Business Strategies
15.10. Lonza
15.10.1.
Company Details
15.10.2.
Company Overview
15.10.3.
Product Offerings
15.10.4.
Key Developments
15.10.5.
Financial Analysis
15.10.6.
SWOT Analysis
15.10.7.
Business Strategies
15.11. Merck KGaA
15.11.1.
Company Details
15.11.2.
Company Overview
15.11.3.
Product Offerings
15.11.4.
Key Developments
15.11.5.
Financial Analysis
15.11.6.
SWOT Analysis
15.11.7. Business Strategies
15.12. MP Biomedicals
15.12.1.
Company Details
15.12.2.
Company Overview
15.12.3.
Product Offerings
15.12.4.
Key Developments
15.12.5.
Financial Analysis
15.12.6.
SWOT Analysis
15.12.7.
Business Strategies
15.13. Novozymes A/S
15.13.1.
Company Details
15.13.2.
Company Overview
15.13.3.
Product Offerings
15.13.4.
Key Developments
15.13.5.
Financial Analysis
15.13.6.
SWOT Analysis
15.13.7.
Business Strategies
15.14. Quality Biological, Inc.
15.14.1.
Company Details
15.14.2.
Company Overview
15.14.3.
Product Offerings
15.14.4.
Key Developments
15.14.5.
Financial Analysis
15.14.6.
SWOT Analysis
15.14.7.
Business Strategies
15.15. SeraCare Life Sciences, Inc.
15.15.1.
Company Details
15.15.2.
Company Overview
15.15.3.
Product Offerings
15.15.4.
Key Developments
15.15.5.
Financial Analysis
15.15.6.
SWOT Analysis
15.15.7.
Business Strategies
15.16. SIAM Bioscience
15.16.1.
Company Details
15.16.2.
Company Overview
15.16.3.
Product Offerings
15.16.4.
Key Developments
15.16.5.
Financial Analysis
15.16.6.
SWOT Analysis
15.16.7.
Business Strategies
15.17. Stemcell Technologies Inc.
15.17.1.
Company Details
15.17.2.
Company Overview
15.17.3.
Product Offerings
15.17.4.
Key Developments
15.17.5.
Financial Analysis
15.17.6.
SWOT Analysis
15.17.7.
Business Strategies
15.18. Thermo Fisher Scientific, Inc.
15.18.1. Company Details
15.18.2. Company Overview
15.18.3. Product Offerings
15.18.4. Key Developments
15.18.5. Financial Analysis
15.18.6. SWOT Analysis
15.18.7. Business Strategies
Note:
This ToC is tentative and can be changed according to the research study
conducted during the course of report completion.
1. Introduction
1.1. Market Scope
1.2. Market Segmentation
1.3. Methodology
1.4. Assumptions
2. Cell Culture Media Market Snapshot
3. Executive Summary: Cell Culture Media Market
4. Qualitative Analysis: Cell Culture Media Market
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Development
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Trends in Market
5. Global Cell Culture Media Market Analysis and Forecasts, 2018
– 2026
5.1. Overview
5.1.1. Global Market Revenue (US$ Mn) and Forecasts
5.2. Global Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Reagent Type
5.2.1. Albumin (Definition, Market Penetration, Market Revenue
Expected to Increase by 2026, Compound Annual Growth Rate (CAGR) and
information on Bovine Serum Albumin, Human Serum Albumin, Recombinant Human
Serum Albumin)
5.2.1.1. Bovine Serum Albumin
5.2.1.2. Human Serum Albumin
5.2.1.3. Recombinant Human Serum Albumin
5.2.2. Hormones
5.2.2.1. Definition
5.2.2.2. Market Penetration
5.2.2.3. Market Revenue Expected to Increase by 2026
5.2.2.4. Compound Annual Growth Rate (CAGR)
5.2.3. Attachment Factors
5.2.3.1. Definition
5.2.3.2. Market Penetration
5.2.3.3. Market Revenue Expected to Increase by 2026
5.2.3.4. Compound Annual Growth Rate (CAGR)
5.2.4. Amino Acid
5.2.4.1. Definition
5.2.4.2. Market Penetration
5.2.4.3. Market Revenue Expected to Increase by 2026
5.2.4.4. Compound Annual Growth Rate (CAGR)
5.2.5. Growth factors and Cytokines (Definition, Market Penetration,
Market Revenue Expected to Increase by 2026, Compound Annual Growth Rate (CAGR)
and information on Tumor Necrosis Factors, Insulin-Like Growth Factors,
Interferons, Interleukins)
5.2.5.1. Tumor Necrosis Factors
5.2.5.2. Insulin-Like Growth Factors
5.2.5.3. Interferons
5.2.5.4. Interleukins
5.3. Key Segment for Channeling Investments
5.3.1. By Reagent Type
6. Global Cell Culture Media Market Analysis and Forecasts, 2018
– 2026
6.1. Overview
6.2. Global Market Revenue (US$ Mn) and Forecasts, By Type
6.2.1. Chemically-Defined Media
6.2.1.1. Definition
6.2.1.2. Market Penetration
6.2.1.3. Market Revenue Expected to Increase by 2026
6.2.1.4. Compound Annual Growth Rate (CAGR)
6.2.2. Classical Media
6.2.2.1. Definition
6.2.2.2. Market Penetration
6.2.2.3. Market Revenue Expected to Increase by 2026
6.2.2.4. Compound Annual Growth Rate (CAGR)
6.2.3. Lysogeny Broth
6.2.3.1. Definition
6.2.3.2. Market Penetration
6.2.3.3. Market Revenue Expected to Increase by 2026
6.2.3.4. Compound Annual Growth Rate (CAGR)
6.2.4. Protein-Free Media
6.2.4.1. Definition
6.2.4.2. Market Penetration
6.2.4.3. Market Revenue Expected to Increase by 2026
6.2.4.4. Compound Annual Growth Rate (CAGR)
6.2.5. Serum-Free Media
6.2.5.1. Definition
6.2.5.2. Market Penetration
6.2.5.3. Market Revenue Expected to Increase by 2026
6.2.5.4. Compound Annual Growth Rate (CAGR)
6.2.6. Specialty Media
6.2.6.1. Definition
6.2.6.2. Market Penetration
6.2.6.3. Market Revenue Expected to Increase by 2026
6.2.6.4. Compound Annual Growth Rate (CAGR)
6.3. Key Segment for Channeling Investments
6.3.1. By Type
7. Global Cell Culture Media Market Analysis and Forecasts, 2018
– 2026
7.1. Overview
7.2. Global Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Application
7.2.1. Biopharmaceuticals and Therapeutics
7.2.1.1. Definition
7.2.1.2. Market Penetration
7.2.1.3. Market Revenue Expected to Increase by 2026
7.2.1.4. Compound Annual Growth Rate (CAGR)
7.2.2. Biotech Research
7.2.2.1. Definition
7.2.2.2. Market Penetration
7.2.2.3. Market Revenue Expected to Increase by 2026
7.2.2.4. Compound Annual Growth Rate (CAGR)
7.2.3. Cancer
7.2.3.1. Definition
7.2.3.2. Market Penetration
7.2.3.3. Market Revenue Expected to Increase by 2026
7.2.3.4. Compound Annual Growth Rate (CAGR)
7.2.4. Drug Screening and Drug Development
7.2.4.1. Definition
7.2.4.2. Market Penetration
7.2.4.3. Market Revenue Expected to Increase by 2026
7.2.4.4. Compound Annual Growth Rate (CAGR)
7.2.5. Regenerative Medicine and Tissue Engineering
7.2.5.1. Definition
7.2.5.2. Market Penetration
7.2.5.3. Market Revenue Expected to Increase by 2026
7.2.5.4. Compound Annual Growth Rate (CAGR)
7.2.6. Stem Cell Technologies
7.2.6.1. Definition
7.2.6.2. Market Penetration
7.2.6.3. Market Revenue Expected to Increase by 2026
7.2.6.4. Compound Annual Growth Rate (CAGR)
7.3. Key Segment for Channeling Investments
7.3.1. By Application
8. Global Cell Culture Media Market Analysis and Forecasts, 2018
– 2026
8.1. Overview
8.2. Global Market Revenue (US$ Mn) and Forecasts, By End User
8.2.1. Biotechnology and Pharmaceutical Companies
8.2.1.1. Definition
8.2.1.2. Market Penetration
8.2.1.3. Market Revenue Expected to Increase by 2026
8.2.1.4. Compound Annual Growth Rate (CAGR)
8.2.2. Research Laboratories
8.2.2.1. Definition
8.2.2.2. Market Penetration
8.2.2.3. Market Revenue Expected to Increase by 2026
8.2.2.4. Compound Annual Growth Rate (CAGR)
8.2.3. Academic Institutes
8.2.3.1. Definition
8.2.3.2. Market Penetration
8.2.3.3. Market Revenue Expected to Increase by 2026
8.2.3.4. Compound Annual Growth Rate (CAGR)
8.2.4. Pathology Labs
8.2.4.1. Definition
8.2.4.2. Market Penetration
8.2.4.3. Market Revenue Expected to Increase by 2026
8.2.4.4. Compound Annual Growth Rate (CAGR)
8.3. Key Segment for Channeling Investments
8.3.1. By End User
9. North America Cell Culture Media Market Analysis and
Forecasts, 2018 – 2026
9.1. Overview
9.1.1. North America Market Revenue (US$ Mn)
9.2. North America Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Reagent Type
9.2.1. Albumin
9.2.1.1. Bovine Serum Albumin
9.2.1.2. Human Serum Albumin
9.2.1.3. Recombinant Human Serum Albumin
9.2.2. Hormones
9.2.3. Attachment Factors
9.2.4. Amino Acid
9.2.5. Growth factors and Cytokines
9.2.5.1. Tumor Necrosis Factors
9.2.5.2. Insulin-Like Growth Factors
9.2.5.3. Interferons
9.2.5.4. Interleukins
9.3. North America Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Type
9.3.1. Chemically-Defined Media
9.3.2. Classical Media
9.3.3. Lysogeny Broth
9.3.4. Protein-Free Media
9.3.5. Serum-Free Media
9.3.6. Specialty Media
9.4. North America Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Application
9.4.1. Biopharmaceuticals and Therapeutics
9.4.2. Biotech Research
9.4.3. Cancer
9.4.4. Drug Screening and Drug Development
9.4.5. Regenerative Medicine and Tissue Engineering
9.4.6. Stem Cell Technologies
9.5. North America Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By End User
9.5.1. Biotechnology and Pharmaceutical Companies
9.5.2. Research Laboratories
9.5.3. Academic Institutes
9.5.4. Pathology Labs
9.6. North America Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Country
9.6.1. U.S.
9.6.1.1. U.S. Market Revenue (US$ Mn) and Forecasts, By Reagent Type
9.6.1.1.1. Albumin
9.6.1.1.1.1. Bovine Serum Albumin
9.6.1.1.1.2. Human Serum Albumin
9.6.1.1.1.3. Recombinant Human Serum Albumin
9.6.1.1.2. Hormones
9.6.1.1.3. Attachment Factors
9.6.1.1.4. Amino Acid
9.6.1.1.5. Growth factors and Cytokines
9.6.1.1.5.1. Tumor Necrosis Factors
9.6.1.1.5.2. Insulin-Like Growth Factors
9.6.1.1.5.3. Interferons
9.6.1.1.5.4. Interleukins
9.6.1.2. U.S. Cell Culture Media Market Revenue (US$ Mn) and Forecasts,
By Type
9.6.1.2.1. Chemically-Defined Media
9.6.1.2.2. Classical Media
9.6.1.2.3. Lysogeny Broth
9.6.1.2.4. Protein-Free Media
9.6.1.2.5. Serum-Free Media
9.6.1.2.6. Specialty Media
9.6.1.3. U.S. Market Revenue (US$ Mn) and Forecasts, By Application
9.6.1.3.1. Biopharmaceuticals and Therapeutics
9.6.1.3.2. Biotech Research
9.6.1.3.3. Cancer
9.6.1.3.4. Drug Screening and Drug Development
9.6.1.3.5. Regenerative Medicine and Tissue Engineering
9.6.1.3.6. Stem Cell Technologies
9.6.1.4. U.S. Cell Culture Media Market Revenue (US$ Mn) and Forecasts,
By End User
9.6.1.4.1. Biotechnology and Pharmaceutical Companies
9.6.1.4.2. Research Laboratories
9.6.1.4.3. Academic Institutes
9.6.1.4.4. Pathology Labs
9.6.2. Rest of North America
9.6.2.1. Rest of North America Cell Culture Media Market Revenue (US$
Mn) and Forecasts, By Reagent Type
9.6.2.1.1. Albumin
9.6.2.1.1.1. Bovine Serum Albumin
9.6.2.1.1.2. Human Serum Albumin
9.6.2.1.1.3. Recombinant Human Serum Albumin
9.6.2.1.2. Hormones
9.6.2.1.3. Attachment Factors
9.6.2.1.4. Amino Acid
9.6.2.1.5. Growth factors and Cytokines
9.6.2.1.5.1. Tumor Necrosis Factors
9.6.2.1.5.2. Insulin-Like Growth Factors
9.6.2.1.5.3. Interferons
9.6.2.1.5.4. Interleukins
9.6.2.2. Rest of North America Cell Culture Media Market Revenue (US$
Mn) and Forecasts, By Type
9.6.2.2.1. Chemically-Defined Media
9.6.2.2.2. Classical Media
9.6.2.2.3. Lysogeny Broth
9.6.2.2.4. Protein-Free Media
9.6.2.2.5. Serum-Free Media
9.6.2.2.6. Specialty Media
9.6.2.3. Rest of North America Market Revenue (US$ Mn) and Forecasts,
By Application
9.6.2.3.1. Biopharmaceuticals and Therapeutics
9.6.2.3.2. Biotech Research
9.6.2.3.3. Cancer
9.6.2.3.4. Drug Screening and Drug Development
9.6.2.3.5. Regenerative Medicine and Tissue Engineering
9.6.2.3.6. Stem Cell Technologies
9.6.2.4. Rest of North America Cell Culture Media Market Revenue (US$
Mn) and Forecasts, By End User
9.6.2.4.1. Biotechnology and Pharmaceutical Companies
9.6.2.4.2. Research Laboratories
9.6.2.4.3. Academic Institutes
9.6.2.4.4. Pathology Labs
9.7. Key Segment for Channeling Investments
9.7.1. By Country
9.7.2. By Reagent Type
9.7.3. By Type
9.7.4. By Application
9.7.5. By End User
10. Europe Cell Culture Media Market Analysis and Forecasts, 2018
– 2026
10.1. Overview
10.1.1. Europe Market Revenue (US$ Mn)
10.2. Europe Market Revenue (US$ Mn) and Forecasts, By Reagent Type
10.2.1. Albumin
10.2.1.1. Bovine Serum Albumin
10.2.1.2. Human Serum Albumin
10.2.1.3. Recombinant Human Serum Albumin
10.2.2. Hormones
10.2.3. Attachment Factors
10.2.4. Amino Acid
10.2.5. Growth factors and Cytokines
10.2.5.1. Tumor Necrosis Factors
10.2.5.2. Insulin-Like Growth Factors
10.2.5.3. Interferons
10.2.5.4. Interleukins
10.3. Europe Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Type
10.3.1. Chemically-Defined Media
10.3.2. Classical Media
10.3.3. Lysogeny Broth
10.3.4. Protein-Free Media
10.3.5. Serum-Free Media
10.3.6. Specialty Media
10.4. Europe Market Revenue (US$ Mn) and Forecasts, By Application
10.4.1. Biopharmaceuticals and Therapeutics
10.4.2. Biotech Research
10.4.3. Cancer
10.4.4. Drug Screening and Drug Development
10.4.5. Regenerative Medicine and Tissue Engineering
10.4.6. Stem Cell Technologies
10.5. Europe Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By End User
10.5.1. Biotechnology and Pharmaceutical Companies
10.5.2. Research Laboratories
10.5.3. Academic Institutes
10.5.4. Pathology Labs
10.6. Europe Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Country
10.6.1. France
10.6.1.1. France Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Reagent Type
10.6.1.1.1. Albumin
10.6.1.1.1.1. Bovine Serum Albumin
10.6.1.1.1.2. Human Serum Albumin
10.6.1.1.1.3. Recombinant Human Serum Albumin
10.6.1.1.2. Hormones
10.6.1.1.3. Attachment Factors
10.6.1.1.4. Amino Acid
10.6.1.1.5. Growth factors and Cytokines
10.6.1.1.5.1.
Tumor Necrosis Factors
10.6.1.1.5.2.
Insulin-Like Growth
Factors
10.6.1.1.5.3.
Interferons
10.6.1.1.5.4.
Interleukins
10.6.1.2. France Market Revenue (US$ Mn) and Forecasts, By Type
10.6.1.2.1. Chemically-Defined Media
10.6.1.2.2. Classical Media
10.6.1.2.3. Lysogeny Broth
10.6.1.2.4. Protein-Free Media
10.6.1.2.5. Serum-Free Media
10.6.1.2.6. Specialty Media
10.6.1.3. France Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Application
10.6.1.3.1. Biopharmaceuticals and Therapeutics
10.6.1.3.2. Biotech Research
10.6.1.3.3. Cancer
10.6.1.3.4. Drug Screening and Drug Development
10.6.1.3.5. Regenerative Medicine and Tissue Engineering
10.6.1.3.6. Stem Cell Technologies
10.6.1.4. France Market Revenue (US$ Mn) and Forecasts, By End User
10.6.1.4.1. Biotechnology and Pharmaceutical Companies
10.6.1.4.2. Research Laboratories
10.6.1.4.3. Academic Institutes
10.6.1.4.4. Pathology Labs
10.6.2. The UK
10.6.2.1. The UK Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Reagent Type
10.6.2.1.1. Albumin
10.6.2.1.1.1. Bovine Serum Albumin
10.6.2.1.1.2. Human Serum Albumin
10.6.2.1.1.3. Recombinant Human Serum Albumin
10.6.2.1.2. Hormones
10.6.2.1.3. Attachment Factors
10.6.2.1.4. Amino Acid
10.6.2.1.5. Growth factors and Cytokines
10.6.2.1.5.1.
Tumor Necrosis Factors
10.6.2.1.5.2.
Insulin-Like Growth
Factors
10.6.2.1.5.3.
Interferons
10.6.2.1.5.4.
Interleukins
10.6.2.2. The UK Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Type
10.6.2.2.1. Chemically-Defined Media
10.6.2.2.2. Classical Media
10.6.2.2.3. Lysogeny Broth
10.6.2.2.4. Protein-Free Media
10.6.2.2.5. Serum-Free Media
10.6.2.2.6. Specialty Media
10.6.2.3. The UK Market Revenue (US$ Mn) and Forecasts, By Application
10.6.2.3.1. Biopharmaceuticals and Therapeutics
10.6.2.3.2. Biotech Research
10.6.2.3.3. Cancer
10.6.2.3.4. Drug Screening and Drug Development
10.6.2.3.5. Regenerative Medicine and Tissue Engineering
10.6.2.3.6. Stem Cell Technologies
10.6.2.4. The UK Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By End User
10.6.2.4.1. Biotechnology and Pharmaceutical Companies
10.6.2.4.2. Research Laboratories
10.6.2.4.3. Academic Institutes
10.6.2.4.4. Pathology Labs
10.6.3. Spain
10.6.3.1. Spain Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Reagent Type
10.6.3.1.1. Albumin
10.6.3.1.1.1.
Bovine Serum Albumin
10.6.3.1.1.2.
Human Serum Albumin
10.6.3.1.1.3.
Recombinant Human Serum
Albumin
10.6.3.1.2. Hormones
10.6.3.1.3. Attachment Factors
10.6.3.1.4. Amino Acid
10.6.3.1.5. Growth factors and Cytokines
10.6.3.1.5.1.
Tumor Necrosis Factors
10.6.3.1.5.2.
Insulin-Like Growth
Factors
10.6.3.1.5.3.
Interferons
10.6.3.1.5.4. Interleukins
10.6.3.2. Spain Market Revenue (US$ Mn) and Forecasts, By Type
10.6.3.2.1. Chemically-Defined Media
10.6.3.2.2. Classical Media
10.6.3.2.3. Lysogeny Broth
10.6.3.2.4. Protein-Free Media
10.6.3.2.5. Serum-Free Media
10.6.3.2.6. Specialty Media
10.6.3.3. Spain Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Application
10.6.3.3.1. Biopharmaceuticals and Therapeutics
10.6.3.3.2. Biotech Research
10.6.3.3.3. Cancer
10.6.3.3.4. Drug Screening and Drug Development
10.6.3.3.5. Regenerative Medicine and Tissue Engineering
10.6.3.3.6. Stem Cell Technologies
10.6.3.4. Spain Market Revenue (US$ Mn) and Forecasts, By End User
10.6.3.4.1. Biotechnology and Pharmaceutical Companies
10.6.3.4.2. Research Laboratories
10.6.3.4.3. Academic Institutes
10.6.3.4.4. Pathology Labs
10.6.4. Germany
10.6.4.1. Germany Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Reagent Type
10.6.4.1.1. Albumin
10.6.4.1.1.1.
Bovine Serum Albumin
10.6.4.1.1.2.
Human Serum Albumin
10.6.4.1.1.3.
Recombinant Human Serum
Albumin
10.6.4.1.2. Hormones
10.6.4.1.3. Attachment Factors
10.6.4.1.4. Amino Acid
10.6.4.1.5. Growth factors and Cytokines
10.6.4.1.5.1.
Tumor Necrosis Factors
10.6.4.1.5.2.
Insulin-Like Growth
Factors
10.6.4.1.5.3.
Interferons
10.6.4.1.5.4.
Interleukins
10.6.4.2. Germany Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Type
10.6.4.2.1. Chemically-Defined Media
10.6.4.2.2. Classical Media
10.6.4.2.3. Lysogeny Broth
10.6.4.2.4. Protein-Free Media
10.6.4.2.5. Serum-Free Media
10.6.4.2.6. Specialty Media
10.6.4.3. Germany Market Revenue (US$ Mn) and Forecasts, By Application
10.6.4.3.1. Biopharmaceuticals and Therapeutics
10.6.4.3.2. Biotech Research
10.6.4.3.3. Cancer
10.6.4.3.4. Drug Screening and Drug Development
10.6.4.3.5. Regenerative Medicine and Tissue Engineering
10.6.4.3.6. Stem Cell Technologies
10.6.4.4. Germany Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By End User
10.6.4.4.1. Biotechnology and Pharmaceutical Companies
10.6.4.4.2. Research Laboratories
10.6.4.4.3. Academic Institutes
10.6.4.4.4. Pathology Labs
10.6.5. Italy
10.6.5.1. Italy Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Reagent Type
10.6.5.1.1. Albumin
10.6.5.1.1.1.
Bovine Serum Albumin
10.6.5.1.1.2.
Human Serum Albumin
10.6.5.1.1.3.
Recombinant Human Serum
Albumin
10.6.5.1.2. Hormones
10.6.5.1.3. Attachment Factors
10.6.5.1.4. Amino Acid
10.6.5.1.5. Growth factors and Cytokines
10.6.5.1.5.1.
Tumor Necrosis Factors
10.6.5.1.5.2.
Insulin-Like Growth
Factors
10.6.5.1.5.3.
Interferons
10.6.5.1.5.4. Interleukins
10.6.5.2. Italy Market Revenue (US$ Mn) and Forecasts, By Type
10.6.5.2.1. Chemically-Defined Media
10.6.5.2.2. Classical Media
10.6.5.2.3. Lysogeny Broth
10.6.5.2.4. Protein-Free Media
10.6.5.2.5. Serum-Free Media
10.6.5.2.6. Specialty Media
10.6.5.3. Italy Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Application
10.6.5.3.1. Biopharmaceuticals and Therapeutics
10.6.5.3.2. Biotech Research
10.6.5.3.3. Cancer
10.6.5.3.4. Drug Screening and Drug Development
10.6.5.3.5. Regenerative Medicine and Tissue Engineering
10.6.5.3.6. Stem Cell Technologies
10.6.5.4. Italy Market Revenue (US$ Mn) and Forecasts, By End User
10.6.5.4.1. Biotechnology and Pharmaceutical Companies
10.6.5.4.2. Research Laboratories
10.6.5.4.3. Academic Institutes
10.6.5.4.4. Pathology Labs
10.6.6. Rest of Europe
10.6.6.1. Rest of Europe Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Reagent Type
10.6.6.1.1. Albumin
10.6.6.1.1.1.
Bovine Serum Albumin
10.6.6.1.1.2.
Human Serum Albumin
10.6.6.1.1.3.
Recombinant Human Serum
Albumin
10.6.6.1.2. Hormones
10.6.6.1.3. Attachment Factors
10.6.6.1.4. Amino Acid
10.6.6.1.5. Growth factors and Cytokines
10.6.6.1.5.1.
Tumor Necrosis Factors
10.6.6.1.5.2.
Insulin-Like Growth
Factors
10.6.6.1.5.3.
Interferons
10.6.6.1.5.4.
Interleukins
10.6.6.2. Rest of Europe Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Type
10.6.6.2.1. Chemically-Defined Media
10.6.6.2.2. Classical Media
10.6.6.2.3. Lysogeny Broth
10.6.6.2.4. Protein-Free Media
10.6.6.2.5. Serum-Free Media
10.6.6.2.6. Specialty Media
10.6.6.3. Rest of Europe Market Revenue (US$ Mn) and Forecasts, By Application
10.6.6.3.1. Biopharmaceuticals and Therapeutics
10.6.6.3.2. Biotech Research
10.6.6.3.3. Cancer
10.6.6.3.4. Drug Screening and Drug Development
10.6.6.3.5. Regenerative Medicine and Tissue Engineering
10.6.6.3.6. Stem Cell Technologies
10.6.6.4. Rest of Europe Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By End User
10.6.6.4.1. Biotechnology and Pharmaceutical Companies
10.6.6.4.2. Research Laboratories
10.6.6.4.3. Academic Institutes
10.6.6.4.4. Pathology Labs
10.7. Key Segment for Channeling Investments
10.7.1. By Country
10.7.2. By Reagent Type
10.7.3. By Type
10.7.4. By Application
10.7.5. By End User
11. Asia Pacific Cell Culture Media Market Analysis and
Forecasts, 2018 – 2026
11.1. Overview
11.1.1. Asia Pacific Market Revenue (US$ Mn)
11.2. Asia Pacific Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Reagent Type
11.2.1. Albumin
11.2.1.1. Bovine Serum Albumin
11.2.1.2. Human Serum Albumin
11.2.1.3. Recombinant Human Serum Albumin
11.2.2. Hormones
11.2.3. Attachment Factors
11.2.4. Amino Acid
11.2.5. Growth factors and Cytokines
11.2.5.1. Tumor Necrosis Factors
11.2.5.2. Insulin-Like Growth Factors
11.2.5.3. Interferons
11.2.5.4. Interleukins
11.3. Asia Pacific Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Type
11.3.1. Chemically-Defined Media
11.3.2. Classical Media
11.3.3. Lysogeny Broth
11.3.4. Protein-Free Media
11.3.5. Serum-Free Media
11.3.6. Specialty Media
11.4. Asia Pacific Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Application
11.4.1. Biopharmaceuticals and Therapeutics
11.4.2. Biotech Research
11.4.3. Cancer
11.4.4. Drug Screening and Drug Development
11.4.5. Regenerative Medicine and Tissue Engineering
11.4.6. Stem Cell Technologies
11.5. Asia Pacific Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By End User
11.5.1. Biotechnology and Pharmaceutical Companies
11.5.2. Research Laboratories
11.5.3. Academic Institutes
11.5.4. Pathology Labs
11.6. Asia Pacific Market Revenue (US$ Mn) and Forecasts, By Country
11.6.1. China
11.6.1.1. China Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Reagent Type
11.6.1.1.1. Albumin
11.6.1.1.1.1.
Bovine Serum Albumin
11.6.1.1.1.2.
Human Serum Albumin
11.6.1.1.1.3.
Recombinant Human Serum
Albumin
11.6.1.1.2. Hormones
11.6.1.1.3. Attachment Factors
11.6.1.1.4. Amino Acid
11.6.1.1.5. Growth factors and Cytokines
11.6.1.1.5.1.
Tumor Necrosis Factors
11.6.1.1.5.2.
Insulin-Like Growth
Factors
11.6.1.1.5.3.
Interferons
11.6.1.1.5.4. Interleukins
11.6.1.2. China Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Type
11.6.1.2.1. Chemically-Defined Media
11.6.1.2.2. Classical Media
11.6.1.2.3. Lysogeny Broth
11.6.1.2.4. Protein-Free Media
11.6.1.2.5. Serum-Free Media
11.6.1.2.6. Specialty Media
11.6.1.3. China Market Revenue (US$ Mn) and Forecasts, By Application
11.6.1.3.1. Biopharmaceuticals and Therapeutics
11.6.1.3.2. Biotech Research
11.6.1.3.3. Cancer
11.6.1.3.4. Drug Screening and Drug Development
11.6.1.3.5. Regenerative Medicine and Tissue Engineering
11.6.1.3.6. Stem Cell Technologies
11.6.1.4. China Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By End User
11.6.1.4.1. Biotechnology and Pharmaceutical Companies
11.6.1.4.2. Research Laboratories
11.6.1.4.3. Academic Institutes
11.6.1.4.4. Pathology Labs
11.6.2. Japan
11.6.2.1. Japan Cell Culture Media Market Revenue (US$ Mn) and Forecasts,
By Reagent Type
11.6.2.1.1. Albumin
11.6.2.1.1.1.
Bovine Serum Albumin
11.6.2.1.1.2.
Human Serum Albumin
11.6.2.1.1.3.
Recombinant Human Serum
Albumin
11.6.2.1.2. Hormones
11.6.2.1.3. Attachment Factors
11.6.2.1.4. Amino Acid
11.6.2.1.5. Growth factors and Cytokines
11.6.2.1.5.1.
Tumor Necrosis Factors
11.6.2.1.5.2.
Insulin-Like Growth
Factors
11.6.2.1.5.3.
Interferons
11.6.2.1.5.4.
Interleukins
11.6.2.2. Japan Market Revenue (US$ Mn) and Forecasts, By Type
11.6.2.2.1. Chemically-Defined Media
11.6.2.2.2. Classical Media
11.6.2.2.3. Lysogeny Broth
11.6.2.2.4. Protein-Free Media
11.6.2.2.5. Serum-Free Media
11.6.2.2.6. Specialty Media
11.6.2.3. Japan Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Application
11.6.2.3.1. Biopharmaceuticals and Therapeutics
11.6.2.3.2. Biotech Research
11.6.2.3.3. Cancer
11.6.2.3.4. Drug Screening and Drug Development
11.6.2.3.5. Regenerative Medicine and Tissue Engineering
11.6.2.3.6. Stem Cell Technologies
11.6.2.4. Japan Market Revenue (US$ Mn) and Forecasts, By End User
11.6.2.4.1. Biotechnology and Pharmaceutical Companies
11.6.2.4.2. Research Laboratories
11.6.2.4.3. Academic Institutes
11.6.2.4.4. Pathology Labs
11.6.3. India
11.6.3.1. India Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Reagent Type
11.6.3.1.1. Albumin
11.6.3.1.1.1.
Bovine Serum Albumin
11.6.3.1.1.2.
Human Serum Albumin
11.6.3.1.1.3.
Recombinant Human Serum
Albumin
11.6.3.1.2. Hormones
11.6.3.1.3. Attachment Factors
11.6.3.1.4. Amino Acid
11.6.3.1.5. Growth factors and Cytokines
11.6.3.1.5.1.
Tumor Necrosis Factors
11.6.3.1.5.2.
Insulin-Like Growth
Factors
11.6.3.1.5.3.
Interferons
11.6.3.1.5.4.
Interleukins
11.6.3.2. India Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Type
11.6.3.2.1. Chemically-Defined Media
11.6.3.2.2. Classical Media
11.6.3.2.3. Lysogeny Broth
11.6.3.2.4. Protein-Free Media
11.6.3.2.5. Serum-Free Media
11.6.3.2.6. Specialty Media
11.6.3.3. India Market Revenue (US$ Mn) and Forecasts, By Application
11.6.3.3.1. Biopharmaceuticals and Therapeutics
11.6.3.3.2. Biotech Research
11.6.3.3.3. Cancer
11.6.3.3.4. Drug Screening and Drug Development
11.6.3.3.5. Regenerative Medicine and Tissue Engineering
11.6.3.3.6. Stem Cell Technologies
11.6.3.4. India Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By End User
11.6.3.4.1. Biotechnology and Pharmaceutical Companies
11.6.3.4.2. Research Laboratories
11.6.3.4.3. Academic Institutes
11.6.3.4.4. Pathology Labs
11.6.4. Southeast Asia
11.6.4.1. Southeast Asia Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Reagent Type
11.6.4.1.1. Albumin
11.6.4.1.1.1.
Bovine Serum Albumin
11.6.4.1.1.2.
Human Serum Albumin
11.6.4.1.1.3.
Recombinant Human Serum
Albumin
11.6.4.1.2. Hormones
11.6.4.1.3. Attachment Factors
11.6.4.1.4. Amino Acid
11.6.4.1.5. Growth factors and Cytokines
11.6.4.1.5.1.
Tumor Necrosis Factors
11.6.4.1.5.2.
Insulin-Like Growth
Factors
11.6.4.1.5.3.
Interferons
11.6.4.1.5.4.
Interleukins
11.6.4.2. Southeast Asia Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Type
11.6.4.2.1. Chemically-Defined Media
11.6.4.2.2. Classical Media
11.6.4.2.3. Lysogeny Broth
11.6.4.2.4. Protein-Free Media
11.6.4.2.5. Serum-Free Media
11.6.4.2.6. Specialty Media
11.6.4.3. Southeast Asia Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Application
11.6.4.3.1. Biopharmaceuticals and Therapeutics
11.6.4.3.2. Biotech Research
11.6.4.3.3. Cancer
11.6.4.3.4. Drug Screening and Drug Development
11.6.4.3.5. Regenerative Medicine and Tissue Engineering
11.6.4.3.6. Stem Cell Technologies
11.6.4.4. Southeast Asia Market Revenue (US$ Mn) and Forecasts, By End
User
11.6.4.4.1. Biotechnology and Pharmaceutical Companies
11.6.4.4.2. Research Laboratories
11.6.4.4.3. Academic Institutes
11.6.4.4.4. Pathology Labs
11.6.5. Rest of Asia Pacific
11.6.5.1. Rest of Asia Pacific Cell Culture Media Market Revenue (US$
Mn) and Forecasts, By Reagent Type
11.6.5.1.1. Albumin
11.6.5.1.1.1.
Bovine Serum Albumin
11.6.5.1.1.2.
Human Serum Albumin
11.6.5.1.1.3.
Recombinant Human Serum
Albumin
11.6.5.1.2. Hormones
11.6.5.1.3. Attachment Factors
11.6.5.1.4. Amino Acid
11.6.5.1.5. Growth factors and Cytokines
11.6.5.1.5.1.
Tumor Necrosis Factors
11.6.5.1.5.2.
Insulin-Like Growth
Factors
11.6.5.1.5.3.
Interferons
11.6.5.1.5.4.
Interleukins
11.6.5.2. Rest of Asia Pacific Cell Culture Media Market Revenue (US$
Mn) and Forecasts, By Type
11.6.5.2.1. Chemically-Defined Media
11.6.5.2.2. Classical Media
11.6.5.2.3. Lysogeny Broth
11.6.5.2.4. Protein-Free Media
11.6.5.2.5. Serum-Free Media
11.6.5.2.6. Specialty Media
11.6.5.3. Rest of Asia Pacific Cell Culture Media Market Revenue (US$
Mn) and Forecasts, By Application
11.6.5.3.1. Biopharmaceuticals and Therapeutics
11.6.5.3.2. Biotech Research
11.6.5.3.3. Cancer
11.6.5.3.4. Drug Screening and Drug Development
11.6.5.3.5. Regenerative Medicine and Tissue Engineering
11.6.5.3.6. Stem Cell Technologies
11.6.5.4. Rest of Asia Pacific Cell Culture Media Market Revenue (US$
Mn) and Forecasts, By End User
11.6.5.4.1. Biotechnology and Pharmaceutical Companies
11.6.5.4.2. Research Laboratories
11.6.5.4.3. Academic Institutes
11.6.5.4.4. Pathology Labs
11.7. Key Segment for Channeling Investments
11.7.1. By Country
11.7.2. By Reagent Type
11.7.3. By Type
11.7.4. By Application
11.7.5. By End User
12. Middle East and Africa Cell Culture Media Market Analysis and
Forecasts, 2018 – 2026
12.1. Overview
12.1.1. Middle East and Africa Market Revenue (US$ Mn)
12.2. Middle East and Africa Cell Culture Media Market Revenue (US$
Mn) and Forecasts, By Reagent Type
12.2.1. Albumin
12.2.1.1. Bovine Serum Albumin
12.2.1.2. Human Serum Albumin
12.2.1.3. Recombinant Human Serum Albumin
12.2.2. Hormones
12.2.3. Attachment Factors
12.2.4. Amino Acid
12.2.5. Growth factors and Cytokines
12.2.5.1. Tumor Necrosis Factors
12.2.5.2. Insulin-Like Growth Factors
12.2.5.3. Interferons
12.2.5.4. Interleukins
12.3. Middle East and Africa Cell Culture Media Market Revenue (US$
Mn) and Forecasts, By Type
12.3.1. Chemically-Defined Media
12.3.2. Classical Media
12.3.3. Lysogeny Broth
12.3.4. Protein-Free Media
12.3.5. Serum-Free Media
12.3.6. Specialty Media
12.4. Middle East and Africa Market Revenue (US$ Mn) and Forecasts,
By Application
12.4.1. Biopharmaceuticals and Therapeutics
12.4.2. Biotech Research
12.4.3. Cancer
12.4.4. Drug Screening and Drug Development
12.4.5. Regenerative Medicine and Tissue Engineering
12.4.6. Stem Cell Technologies
12.5. Middle East and Africa Cell Culture Media Market Revenue (US$
Mn) and Forecasts, By End User
12.5.1. Biotechnology and Pharmaceutical Companies
12.5.2. Research Laboratories
12.5.3. Academic Institutes
12.5.4. Pathology Labs
12.6. Middle East and Africa Cell Culture Media Market Revenue (US$
Mn) and Forecasts, By Country
12.6.1. GCC Countries
12.6.1.1. GCC Countries Market Revenue (US$ Mn) and Forecasts, By
Reagent Type
12.6.1.1.1. Albumin
12.6.1.1.1.1.
Bovine Serum Albumin
12.6.1.1.1.2.
Human Serum Albumin
12.6.1.1.1.3.
Recombinant Human Serum
Albumin
12.6.1.1.2. Hormones
12.6.1.1.3. Attachment Factors
12.6.1.1.4. Amino Acid
12.6.1.1.5. Growth factors and Cytokines
12.6.1.1.5.1.
Tumor Necrosis Factors
12.6.1.1.5.2.
Insulin-Like Growth
Factors
12.6.1.1.5.3.
Interferons
12.6.1.1.5.4.
Interleukins
12.6.1.2. GCC Countries Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Type
12.6.1.2.1. Chemically-Defined Media
12.6.1.2.2. Classical Media
12.6.1.2.3. Lysogeny Broth
12.6.1.2.4. Protein-Free Media
12.6.1.2.5. Serum-Free Media
12.6.1.2.6. Specialty Media
12.6.1.3. GCC Countries Market Revenue (US$ Mn) and Forecasts, By
Application
12.6.1.3.1. Biopharmaceuticals and Therapeutics
12.6.1.3.2. Biotech Research
12.6.1.3.3. Cancer
12.6.1.3.4. Drug Screening and Drug Development
12.6.1.3.5. Regenerative Medicine and Tissue Engineering
12.6.1.3.6. Stem Cell Technologies
12.6.1.4. GCC Countries Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By End User
12.6.1.4.1. Biotechnology and Pharmaceutical Companies
12.6.1.4.2. Research Laboratories
12.6.1.4.3. Academic Institutes
12.6.1.4.4. Pathology Labs
12.6.2. Southern Africa
12.6.2.1. Southern Africa Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Reagent Type
12.6.2.1.1. Albumin
12.6.2.1.1.1.
Bovine Serum Albumin
12.6.2.1.1.2.
Human Serum Albumin
12.6.2.1.1.3.
Recombinant Human Serum
Albumin
12.6.2.1.2. Hormones
12.6.2.1.3. Attachment Factors
12.6.2.1.4. Amino Acid
12.6.2.1.5. Growth factors and Cytokines
12.6.2.1.5.1.
Tumor Necrosis Factors
12.6.2.1.5.2.
Insulin-Like Growth
Factors
12.6.2.1.5.3.
Interferons
12.6.2.1.5.4.
Interleukins
12.6.2.2. Southern Africa Market Revenue (US$ Mn) and Forecasts, By Type
12.6.2.2.1. Chemically-Defined Media
12.6.2.2.2. Classical Media
12.6.2.2.3. Lysogeny Broth
12.6.2.2.4. Protein-Free Media
12.6.2.2.5. Serum-Free Media
12.6.2.2.6. Specialty Media
12.6.2.3. Southern Africa Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Application
12.6.2.3.1. Biopharmaceuticals and Therapeutics
12.6.2.3.2. Biotech Research
12.6.2.3.3. Cancer
12.6.2.3.4. Drug Screening and Drug Development
12.6.2.3.5. Regenerative Medicine and Tissue Engineering
12.6.2.3.6. Stem Cell Technologies
12.6.2.4. Southern Africa Market Revenue (US$ Mn) and Forecasts, By End
User
12.6.2.4.1. Biotechnology and Pharmaceutical Companies
12.6.2.4.2. Research Laboratories
12.6.2.4.3. Academic Institutes
12.6.2.4.4. Pathology Labs
12.6.3. Rest of MEA
12.6.3.1. Rest of MEA Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Reagent Type
12.6.3.1.1. Albumin
12.6.3.1.1.1.
Bovine Serum Albumin
12.6.3.1.1.2.
Human Serum Albumin
12.6.3.1.1.3.
Recombinant Human Serum
Albumin
12.6.3.1.2. Hormones
12.6.3.1.3. Attachment Factors
12.6.3.1.4. Amino Acid
12.6.3.1.5. Growth factors and Cytokines
12.6.3.1.5.1.
Tumor Necrosis Factors
12.6.3.1.5.2.
Insulin-Like Growth
Factors
12.6.3.1.5.3.
Interferons
12.6.3.1.5.4. Interleukins
12.6.3.2. Rest of MEA Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Type
12.6.3.2.1. Chemically-Defined Media
12.6.3.2.2. Classical Media
12.6.3.2.3. Lysogeny Broth
12.6.3.2.4. Protein-Free Media
12.6.3.2.5. Serum-Free Media
12.6.3.2.6. Specialty Media
12.6.3.3. Rest of MEA Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Application
12.6.3.3.1. Biopharmaceuticals and Therapeutics
12.6.3.3.2. Biotech Research
12.6.3.3.3. Cancer
12.6.3.3.4. Drug Screening and Drug Development
12.6.3.3.5. Regenerative Medicine and Tissue Engineering
12.6.3.3.6. Stem Cell Technologies
12.6.3.4. Rest of MEA Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By End User
12.6.3.4.1. Biotechnology and Pharmaceutical Companies
12.6.3.4.2. Research Laboratories
12.6.3.4.3. Academic Institutes
12.6.3.4.4. Pathology Labs
12.7. Key Segment for Channeling Investments
12.7.1. By Country
12.7.2. By Reagent Type
12.7.3. By Type
12.7.4. By Application
12.7.5. By End User
13. Latin America Cell Culture Media Market Analysis and
Forecasts, 2018 – 2026
13.1. Overview
13.1.1. Latin America Market Revenue (US$ Mn)
13.2. Latin America Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Reagent Type
13.2.1. Albumin
13.2.1.1. Bovine Serum Albumin
13.2.1.2. Human Serum Albumin
13.2.1.3. Recombinant Human Serum Albumin
13.2.2. Hormones
13.2.3. Attachment Factors
13.2.4. Amino Acid
13.2.5. Growth factors and Cytokines
13.2.5.1. Tumor Necrosis Factors
13.2.5.2. Insulin-Like Growth Factors
13.2.5.3. Interferons
13.2.5.4. Interleukins
13.3. Latin America Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Type
13.3.1. Chemically-Defined Media
13.3.2. Classical Media
13.3.3. Lysogeny Broth
13.3.4. Protein-Free Media
13.3.5. Serum-Free Media
13.3.6. Specialty Media
13.4. Latin America Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Application
13.4.1. Biopharmaceuticals and Therapeutics
13.4.2. Biotech Research
13.4.3. Cancer
13.4.4. Drug Screening and Drug Development
13.4.5. Regenerative Medicine and Tissue Engineering
13.4.6. Stem Cell Technologies
13.5. Latin America Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By End User
13.5.1. Biotechnology and Pharmaceutical Companies
13.5.2. Research Laboratories
13.5.3. Academic Institutes
13.5.4. Pathology Labs
13.6. Latin America Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Country
13.6.1. Brazil
13.6.1.1. Brazil Market Revenue (US$ Mn) and Forecasts, By Reagent Type
13.6.1.1.1. Albumin
13.6.1.1.1.1.
Bovine Serum Albumin
13.6.1.1.1.2.
Human Serum Albumin
13.6.1.1.1.3.
Recombinant Human Serum
Albumin
13.6.1.1.2. Hormones
13.6.1.1.3. Attachment Factors
13.6.1.1.4. Amino Acid
13.6.1.1.5. Growth factors and Cytokines
13.6.1.1.5.1.
Tumor Necrosis Factors
13.6.1.1.5.2.
Insulin-Like Growth Factors
13.6.1.1.5.3.
Interferons
13.6.1.1.5.4. Interleukins
13.6.1.2. Brazil Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Type
13.6.1.2.1. Chemically-Defined Media
13.6.1.2.2. Classical Media
13.6.1.2.3. Lysogeny Broth
13.6.1.2.4. Protein-Free Media
13.6.1.2.5. Serum-Free Media
13.6.1.2.6. Specialty Media
13.6.1.3. Brazil Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Application
13.6.1.3.1. Biopharmaceuticals and Therapeutics
13.6.1.3.2. Biotech Research
13.6.1.3.3. Cancer
13.6.1.3.4. Drug Screening and Drug Development
13.6.1.3.5. Regenerative Medicine and Tissue Engineering
13.6.1.3.6. Stem Cell Technologies
13.6.1.4. Brazil Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By End User
13.6.1.4.1. Biotechnology and Pharmaceutical Companies
13.6.1.4.2. Research Laboratories
13.6.1.4.3. Academic Institutes
13.6.1.4.4. Pathology Labs
13.6.2. Rest of Latin America
13.6.2.1. Rest of Latin America Cell Culture Media Market Revenue (US$
Mn) and Forecasts, By Reagent Type
13.6.2.1.1. Albumin
13.6.2.1.1.1.
Bovine Serum Albumin
13.6.2.1.1.2.
Human Serum Albumin
13.6.2.1.1.3.
Recombinant Human Serum
Albumin
13.6.2.1.2. Hormones
13.6.2.1.3. Attachment Factors
13.6.2.1.4. Amino Acid
13.6.2.1.5. Growth factors and Cytokines
13.6.2.1.5.1.
Tumor Necrosis Factors
13.6.2.1.5.2.
Insulin-Like Growth
Factors
13.6.2.1.5.3.
Interferons
13.6.2.1.5.4.
Interleukins
13.6.2.2. Rest of Latin America Cell Culture Media Market Revenue (US$
Mn) and Forecasts, By Type
13.6.2.2.1. Chemically-Defined Media
13.6.2.2.2. Classical Media
13.6.2.2.3. Lysogeny Broth
13.6.2.2.4. Protein-Free Media
13.6.2.2.5. Serum-Free Media
13.6.2.2.6. Specialty Media
13.6.2.3. Rest of Latin America Market Revenue (US$ Mn) and Forecasts,
By Application
13.6.2.3.1. Biopharmaceuticals and Therapeutics
13.6.2.3.2. Biotech Research
13.6.2.3.3. Cancer
13.6.2.3.4. Drug Screening and Drug Development
13.6.2.3.5. Regenerative Medicine and Tissue Engineering
13.6.2.3.6. Stem Cell Technologies
13.6.2.4. Rest of Latin America Cell Culture Media Market Revenue (US$ Mn)
and Forecasts, By End User
13.6.2.4.1. Biotechnology and Pharmaceutical Companies
13.6.2.4.2. Research Laboratories
13.6.2.4.3. Academic Institutes
13.6.2.4.4. Pathology Labs
13.7. Key Segment for Channeling Investments
13.7.1. By Country
13.7.2. By Reagent Type
13.7.3. By Type
13.7.4. By Application
13.7.5. By End User
14. Competitive Benchmarking
14.1. Player Positioning Analysis
14.2. Global Presence and Growth Strategies
15. Player Profiles
15.1. Affymetrix, Inc.
15.1.1. Company Details
15.1.2. Company Overview
15.1.3. Product Offerings
15.1.4. Key Developments
15.1.5. Financial Analysis
15.1.6. SWOT Analysis
15.1.7. Business Strategies
15.2. Analytical Biological Services Inc.
15.2.1. Company Details
15.2.2. Company Overview
15.2.3. Product Offerings
15.2.4. Key Developments
15.2.5. Financial Analysis
15.2.6. SWOT Analysis
15.2.7. Business Strategies
15.3. BD Biosciences
15.3.1. Company Details
15.3.2. Company Overview
15.3.3. Product Offerings
15.3.4. Key Developments
15.3.5. Financial Analysis
15.3.6. SWOT Analysis
15.3.7. Business Strategies
15.4. Bio-Techne Corporation
15.4.1. Company Details
15.4.2. Company Overview
15.4.3. Product Offerings
15.4.4. Key Developments
15.4.5. Financial Analysis
15.4.6. SWOT Analysis
15.4.7. Business Strategies
15.5. Cell Essentials, Inc.
15.5.1. Company Details
15.5.2. Company Overview
15.5.3. Product Offerings
15.5.4. Key Developments
15.5.5. Financial Analysis
15.5.6. SWOT Analysis
15.5.7. Business Strategies
15.6. ClonTech Laboratories, Inc.
15.6.1. Company Details
15.6.2. Company Overview
15.6.3. Product Offerings
15.6.4. Key Developments
15.6.5. Financial Analysis
15.6.6. SWOT Analysis
15.6.7. Business Strategies
15.7. GE Healthcare
15.7.1. Company Details
15.7.2. Company Overview
15.7.3. Product Offerings
15.7.4. Key Developments
15.7.5. Financial Analysis
15.7.6. SWOT Analysis
15.7.7. Business Strategies
15.8. J R Scientific Inc.
15.8.1. Company Details
15.8.2. Company Overview
15.8.3. Product Offerings
15.8.4. Key Developments
15.8.5. Financial Analysis
15.8.6. SWOT Analysis
15.8.7. Business Strategies
15.9. Johnson & Johnson
15.9.1. Company Details
15.9.2. Company Overview
15.9.3. Product Offerings
15.9.4. Key Developments
15.9.5. Financial Analysis
15.9.6. SWOT Analysis
15.9.7. Business Strategies
15.10. Lonza
15.10.1.
Company Details
15.10.2.
Company Overview
15.10.3.
Product Offerings
15.10.4.
Key Developments
15.10.5.
Financial Analysis
15.10.6.
SWOT Analysis
15.10.7.
Business Strategies
15.11. Merck KGaA
15.11.1.
Company Details
15.11.2.
Company Overview
15.11.3.
Product Offerings
15.11.4.
Key Developments
15.11.5.
Financial Analysis
15.11.6.
SWOT Analysis
15.11.7. Business Strategies
15.12. MP Biomedicals
15.12.1.
Company Details
15.12.2.
Company Overview
15.12.3.
Product Offerings
15.12.4.
Key Developments
15.12.5.
Financial Analysis
15.12.6.
SWOT Analysis
15.12.7.
Business Strategies
15.13. Novozymes A/S
15.13.1.
Company Details
15.13.2.
Company Overview
15.13.3.
Product Offerings
15.13.4.
Key Developments
15.13.5.
Financial Analysis
15.13.6.
SWOT Analysis
15.13.7.
Business Strategies
15.14. Quality Biological, Inc.
15.14.1.
Company Details
15.14.2.
Company Overview
15.14.3.
Product Offerings
15.14.4.
Key Developments
15.14.5.
Financial Analysis
15.14.6.
SWOT Analysis
15.14.7.
Business Strategies
15.15. SeraCare Life Sciences, Inc.
15.15.1.
Company Details
15.15.2.
Company Overview
15.15.3.
Product Offerings
15.15.4.
Key Developments
15.15.5.
Financial Analysis
15.15.6.
SWOT Analysis
15.15.7.
Business Strategies
15.16. SIAM Bioscience
15.16.1.
Company Details
15.16.2.
Company Overview
15.16.3.
Product Offerings
15.16.4.
Key Developments
15.16.5.
Financial Analysis
15.16.6.
SWOT Analysis
15.16.7.
Business Strategies
15.17. Stemcell Technologies Inc.
15.17.1.
Company Details
15.17.2.
Company Overview
15.17.3.
Product Offerings
15.17.4.
Key Developments
15.17.5.
Financial Analysis
15.17.6.
SWOT Analysis
15.17.7.
Business Strategies
15.18. Thermo Fisher Scientific, Inc.
15.18.1. Company Details
15.18.2. Company Overview
15.18.3. Product Offerings
15.18.4. Key Developments
15.18.5. Financial Analysis
15.18.6. SWOT Analysis
15.18.7. Business Strategies
Note:
This ToC is tentative and can be changed according to the research study
conducted during the course of report completion.
1. Introduction
1.1. Market Scope
1.2. Market Segmentation
1.3. Methodology
1.4. Assumptions
2. Cell Culture Media Market Snapshot
3. Executive Summary: Cell Culture Media Market
4. Qualitative Analysis: Cell Culture Media Market
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Development
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Trends in Market
5. Global Cell Culture Media Market Analysis and Forecasts, 2018
– 2026
5.1. Overview
5.1.1. Global Market Revenue (US$ Mn) and Forecasts
5.2. Global Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Reagent Type
5.2.1. Albumin (Definition, Market Penetration, Market Revenue
Expected to Increase by 2026, Compound Annual Growth Rate (CAGR) and
information on Bovine Serum Albumin, Human Serum Albumin, Recombinant Human
Serum Albumin)
5.2.1.1. Bovine Serum Albumin
5.2.1.2. Human Serum Albumin
5.2.1.3. Recombinant Human Serum Albumin
5.2.2. Hormones
5.2.2.1. Definition
5.2.2.2. Market Penetration
5.2.2.3. Market Revenue Expected to Increase by 2026
5.2.2.4. Compound Annual Growth Rate (CAGR)
5.2.3. Attachment Factors
5.2.3.1. Definition
5.2.3.2. Market Penetration
5.2.3.3. Market Revenue Expected to Increase by 2026
5.2.3.4. Compound Annual Growth Rate (CAGR)
5.2.4. Amino Acid
5.2.4.1. Definition
5.2.4.2. Market Penetration
5.2.4.3. Market Revenue Expected to Increase by 2026
5.2.4.4. Compound Annual Growth Rate (CAGR)
5.2.5. Growth factors and Cytokines (Definition, Market Penetration,
Market Revenue Expected to Increase by 2026, Compound Annual Growth Rate (CAGR)
and information on Tumor Necrosis Factors, Insulin-Like Growth Factors,
Interferons, Interleukins)
5.2.5.1. Tumor Necrosis Factors
5.2.5.2. Insulin-Like Growth Factors
5.2.5.3. Interferons
5.2.5.4. Interleukins
5.3. Key Segment for Channeling Investments
5.3.1. By Reagent Type
6. Global Cell Culture Media Market Analysis and Forecasts, 2018
– 2026
6.1. Overview
6.2. Global Market Revenue (US$ Mn) and Forecasts, By Type
6.2.1. Chemically-Defined Media
6.2.1.1. Definition
6.2.1.2. Market Penetration
6.2.1.3. Market Revenue Expected to Increase by 2026
6.2.1.4. Compound Annual Growth Rate (CAGR)
6.2.2. Classical Media
6.2.2.1. Definition
6.2.2.2. Market Penetration
6.2.2.3. Market Revenue Expected to Increase by 2026
6.2.2.4. Compound Annual Growth Rate (CAGR)
6.2.3. Lysogeny Broth
6.2.3.1. Definition
6.2.3.2. Market Penetration
6.2.3.3. Market Revenue Expected to Increase by 2026
6.2.3.4. Compound Annual Growth Rate (CAGR)
6.2.4. Protein-Free Media
6.2.4.1. Definition
6.2.4.2. Market Penetration
6.2.4.3. Market Revenue Expected to Increase by 2026
6.2.4.4. Compound Annual Growth Rate (CAGR)
6.2.5. Serum-Free Media
6.2.5.1. Definition
6.2.5.2. Market Penetration
6.2.5.3. Market Revenue Expected to Increase by 2026
6.2.5.4. Compound Annual Growth Rate (CAGR)
6.2.6. Specialty Media
6.2.6.1. Definition
6.2.6.2. Market Penetration
6.2.6.3. Market Revenue Expected to Increase by 2026
6.2.6.4. Compound Annual Growth Rate (CAGR)
6.3. Key Segment for Channeling Investments
6.3.1. By Type
7. Global Cell Culture Media Market Analysis and Forecasts, 2018
– 2026
7.1. Overview
7.2. Global Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Application
7.2.1. Biopharmaceuticals and Therapeutics
7.2.1.1. Definition
7.2.1.2. Market Penetration
7.2.1.3. Market Revenue Expected to Increase by 2026
7.2.1.4. Compound Annual Growth Rate (CAGR)
7.2.2. Biotech Research
7.2.2.1. Definition
7.2.2.2. Market Penetration
7.2.2.3. Market Revenue Expected to Increase by 2026
7.2.2.4. Compound Annual Growth Rate (CAGR)
7.2.3. Cancer
7.2.3.1. Definition
7.2.3.2. Market Penetration
7.2.3.3. Market Revenue Expected to Increase by 2026
7.2.3.4. Compound Annual Growth Rate (CAGR)
7.2.4. Drug Screening and Drug Development
7.2.4.1. Definition
7.2.4.2. Market Penetration
7.2.4.3. Market Revenue Expected to Increase by 2026
7.2.4.4. Compound Annual Growth Rate (CAGR)
7.2.5. Regenerative Medicine and Tissue Engineering
7.2.5.1. Definition
7.2.5.2. Market Penetration
7.2.5.3. Market Revenue Expected to Increase by 2026
7.2.5.4. Compound Annual Growth Rate (CAGR)
7.2.6. Stem Cell Technologies
7.2.6.1. Definition
7.2.6.2. Market Penetration
7.2.6.3. Market Revenue Expected to Increase by 2026
7.2.6.4. Compound Annual Growth Rate (CAGR)
7.3. Key Segment for Channeling Investments
7.3.1. By Application
8. Global Cell Culture Media Market Analysis and Forecasts, 2018
– 2026
8.1. Overview
8.2. Global Market Revenue (US$ Mn) and Forecasts, By End User
8.2.1. Biotechnology and Pharmaceutical Companies
8.2.1.1. Definition
8.2.1.2. Market Penetration
8.2.1.3. Market Revenue Expected to Increase by 2026
8.2.1.4. Compound Annual Growth Rate (CAGR)
8.2.2. Research Laboratories
8.2.2.1. Definition
8.2.2.2. Market Penetration
8.2.2.3. Market Revenue Expected to Increase by 2026
8.2.2.4. Compound Annual Growth Rate (CAGR)
8.2.3. Academic Institutes
8.2.3.1. Definition
8.2.3.2. Market Penetration
8.2.3.3. Market Revenue Expected to Increase by 2026
8.2.3.4. Compound Annual Growth Rate (CAGR)
8.2.4. Pathology Labs
8.2.4.1. Definition
8.2.4.2. Market Penetration
8.2.4.3. Market Revenue Expected to Increase by 2026
8.2.4.4. Compound Annual Growth Rate (CAGR)
8.3. Key Segment for Channeling Investments
8.3.1. By End User
9. North America Cell Culture Media Market Analysis and
Forecasts, 2018 – 2026
9.1. Overview
9.1.1. North America Market Revenue (US$ Mn)
9.2. North America Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Reagent Type
9.2.1. Albumin
9.2.1.1. Bovine Serum Albumin
9.2.1.2. Human Serum Albumin
9.2.1.3. Recombinant Human Serum Albumin
9.2.2. Hormones
9.2.3. Attachment Factors
9.2.4. Amino Acid
9.2.5. Growth factors and Cytokines
9.2.5.1. Tumor Necrosis Factors
9.2.5.2. Insulin-Like Growth Factors
9.2.5.3. Interferons
9.2.5.4. Interleukins
9.3. North America Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Type
9.3.1. Chemically-Defined Media
9.3.2. Classical Media
9.3.3. Lysogeny Broth
9.3.4. Protein-Free Media
9.3.5. Serum-Free Media
9.3.6. Specialty Media
9.4. North America Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Application
9.4.1. Biopharmaceuticals and Therapeutics
9.4.2. Biotech Research
9.4.3. Cancer
9.4.4. Drug Screening and Drug Development
9.4.5. Regenerative Medicine and Tissue Engineering
9.4.6. Stem Cell Technologies
9.5. North America Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By End User
9.5.1. Biotechnology and Pharmaceutical Companies
9.5.2. Research Laboratories
9.5.3. Academic Institutes
9.5.4. Pathology Labs
9.6. North America Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Country
9.6.1. U.S.
9.6.1.1. U.S. Market Revenue (US$ Mn) and Forecasts, By Reagent Type
9.6.1.1.1. Albumin
9.6.1.1.1.1. Bovine Serum Albumin
9.6.1.1.1.2. Human Serum Albumin
9.6.1.1.1.3. Recombinant Human Serum Albumin
9.6.1.1.2. Hormones
9.6.1.1.3. Attachment Factors
9.6.1.1.4. Amino Acid
9.6.1.1.5. Growth factors and Cytokines
9.6.1.1.5.1. Tumor Necrosis Factors
9.6.1.1.5.2. Insulin-Like Growth Factors
9.6.1.1.5.3. Interferons
9.6.1.1.5.4. Interleukins
9.6.1.2. U.S. Cell Culture Media Market Revenue (US$ Mn) and Forecasts,
By Type
9.6.1.2.1. Chemically-Defined Media
9.6.1.2.2. Classical Media
9.6.1.2.3. Lysogeny Broth
9.6.1.2.4. Protein-Free Media
9.6.1.2.5. Serum-Free Media
9.6.1.2.6. Specialty Media
9.6.1.3. U.S. Market Revenue (US$ Mn) and Forecasts, By Application
9.6.1.3.1. Biopharmaceuticals and Therapeutics
9.6.1.3.2. Biotech Research
9.6.1.3.3. Cancer
9.6.1.3.4. Drug Screening and Drug Development
9.6.1.3.5. Regenerative Medicine and Tissue Engineering
9.6.1.3.6. Stem Cell Technologies
9.6.1.4. U.S. Cell Culture Media Market Revenue (US$ Mn) and Forecasts,
By End User
9.6.1.4.1. Biotechnology and Pharmaceutical Companies
9.6.1.4.2. Research Laboratories
9.6.1.4.3. Academic Institutes
9.6.1.4.4. Pathology Labs
9.6.2. Rest of North America
9.6.2.1. Rest of North America Cell Culture Media Market Revenue (US$
Mn) and Forecasts, By Reagent Type
9.6.2.1.1. Albumin
9.6.2.1.1.1. Bovine Serum Albumin
9.6.2.1.1.2. Human Serum Albumin
9.6.2.1.1.3. Recombinant Human Serum Albumin
9.6.2.1.2. Hormones
9.6.2.1.3. Attachment Factors
9.6.2.1.4. Amino Acid
9.6.2.1.5. Growth factors and Cytokines
9.6.2.1.5.1. Tumor Necrosis Factors
9.6.2.1.5.2. Insulin-Like Growth Factors
9.6.2.1.5.3. Interferons
9.6.2.1.5.4. Interleukins
9.6.2.2. Rest of North America Cell Culture Media Market Revenue (US$
Mn) and Forecasts, By Type
9.6.2.2.1. Chemically-Defined Media
9.6.2.2.2. Classical Media
9.6.2.2.3. Lysogeny Broth
9.6.2.2.4. Protein-Free Media
9.6.2.2.5. Serum-Free Media
9.6.2.2.6. Specialty Media
9.6.2.3. Rest of North America Market Revenue (US$ Mn) and Forecasts,
By Application
9.6.2.3.1. Biopharmaceuticals and Therapeutics
9.6.2.3.2. Biotech Research
9.6.2.3.3. Cancer
9.6.2.3.4. Drug Screening and Drug Development
9.6.2.3.5. Regenerative Medicine and Tissue Engineering
9.6.2.3.6. Stem Cell Technologies
9.6.2.4. Rest of North America Cell Culture Media Market Revenue (US$
Mn) and Forecasts, By End User
9.6.2.4.1. Biotechnology and Pharmaceutical Companies
9.6.2.4.2. Research Laboratories
9.6.2.4.3. Academic Institutes
9.6.2.4.4. Pathology Labs
9.7. Key Segment for Channeling Investments
9.7.1. By Country
9.7.2. By Reagent Type
9.7.3. By Type
9.7.4. By Application
9.7.5. By End User
10. Europe Cell Culture Media Market Analysis and Forecasts, 2018
– 2026
10.1. Overview
10.1.1. Europe Market Revenue (US$ Mn)
10.2. Europe Market Revenue (US$ Mn) and Forecasts, By Reagent Type
10.2.1. Albumin
10.2.1.1. Bovine Serum Albumin
10.2.1.2. Human Serum Albumin
10.2.1.3. Recombinant Human Serum Albumin
10.2.2. Hormones
10.2.3. Attachment Factors
10.2.4. Amino Acid
10.2.5. Growth factors and Cytokines
10.2.5.1. Tumor Necrosis Factors
10.2.5.2. Insulin-Like Growth Factors
10.2.5.3. Interferons
10.2.5.4. Interleukins
10.3. Europe Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Type
10.3.1. Chemically-Defined Media
10.3.2. Classical Media
10.3.3. Lysogeny Broth
10.3.4. Protein-Free Media
10.3.5. Serum-Free Media
10.3.6. Specialty Media
10.4. Europe Market Revenue (US$ Mn) and Forecasts, By Application
10.4.1. Biopharmaceuticals and Therapeutics
10.4.2. Biotech Research
10.4.3. Cancer
10.4.4. Drug Screening and Drug Development
10.4.5. Regenerative Medicine and Tissue Engineering
10.4.6. Stem Cell Technologies
10.5. Europe Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By End User
10.5.1. Biotechnology and Pharmaceutical Companies
10.5.2. Research Laboratories
10.5.3. Academic Institutes
10.5.4. Pathology Labs
10.6. Europe Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Country
10.6.1. France
10.6.1.1. France Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Reagent Type
10.6.1.1.1. Albumin
10.6.1.1.1.1. Bovine Serum Albumin
10.6.1.1.1.2. Human Serum Albumin
10.6.1.1.1.3. Recombinant Human Serum Albumin
10.6.1.1.2. Hormones
10.6.1.1.3. Attachment Factors
10.6.1.1.4. Amino Acid
10.6.1.1.5. Growth factors and Cytokines
10.6.1.1.5.1.
Tumor Necrosis Factors
10.6.1.1.5.2.
Insulin-Like Growth
Factors
10.6.1.1.5.3.
Interferons
10.6.1.1.5.4.
Interleukins
10.6.1.2. France Market Revenue (US$ Mn) and Forecasts, By Type
10.6.1.2.1. Chemically-Defined Media
10.6.1.2.2. Classical Media
10.6.1.2.3. Lysogeny Broth
10.6.1.2.4. Protein-Free Media
10.6.1.2.5. Serum-Free Media
10.6.1.2.6. Specialty Media
10.6.1.3. France Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Application
10.6.1.3.1. Biopharmaceuticals and Therapeutics
10.6.1.3.2. Biotech Research
10.6.1.3.3. Cancer
10.6.1.3.4. Drug Screening and Drug Development
10.6.1.3.5. Regenerative Medicine and Tissue Engineering
10.6.1.3.6. Stem Cell Technologies
10.6.1.4. France Market Revenue (US$ Mn) and Forecasts, By End User
10.6.1.4.1. Biotechnology and Pharmaceutical Companies
10.6.1.4.2. Research Laboratories
10.6.1.4.3. Academic Institutes
10.6.1.4.4. Pathology Labs
10.6.2. The UK
10.6.2.1. The UK Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Reagent Type
10.6.2.1.1. Albumin
10.6.2.1.1.1. Bovine Serum Albumin
10.6.2.1.1.2. Human Serum Albumin
10.6.2.1.1.3. Recombinant Human Serum Albumin
10.6.2.1.2. Hormones
10.6.2.1.3. Attachment Factors
10.6.2.1.4. Amino Acid
10.6.2.1.5. Growth factors and Cytokines
10.6.2.1.5.1.
Tumor Necrosis Factors
10.6.2.1.5.2.
Insulin-Like Growth
Factors
10.6.2.1.5.3.
Interferons
10.6.2.1.5.4.
Interleukins
10.6.2.2. The UK Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Type
10.6.2.2.1. Chemically-Defined Media
10.6.2.2.2. Classical Media
10.6.2.2.3. Lysogeny Broth
10.6.2.2.4. Protein-Free Media
10.6.2.2.5. Serum-Free Media
10.6.2.2.6. Specialty Media
10.6.2.3. The UK Market Revenue (US$ Mn) and Forecasts, By Application
10.6.2.3.1. Biopharmaceuticals and Therapeutics
10.6.2.3.2. Biotech Research
10.6.2.3.3. Cancer
10.6.2.3.4. Drug Screening and Drug Development
10.6.2.3.5. Regenerative Medicine and Tissue Engineering
10.6.2.3.6. Stem Cell Technologies
10.6.2.4. The UK Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By End User
10.6.2.4.1. Biotechnology and Pharmaceutical Companies
10.6.2.4.2. Research Laboratories
10.6.2.4.3. Academic Institutes
10.6.2.4.4. Pathology Labs
10.6.3. Spain
10.6.3.1. Spain Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Reagent Type
10.6.3.1.1. Albumin
10.6.3.1.1.1.
Bovine Serum Albumin
10.6.3.1.1.2.
Human Serum Albumin
10.6.3.1.1.3.
Recombinant Human Serum
Albumin
10.6.3.1.2. Hormones
10.6.3.1.3. Attachment Factors
10.6.3.1.4. Amino Acid
10.6.3.1.5. Growth factors and Cytokines
10.6.3.1.5.1.
Tumor Necrosis Factors
10.6.3.1.5.2.
Insulin-Like Growth
Factors
10.6.3.1.5.3.
Interferons
10.6.3.1.5.4. Interleukins
10.6.3.2. Spain Market Revenue (US$ Mn) and Forecasts, By Type
10.6.3.2.1. Chemically-Defined Media
10.6.3.2.2. Classical Media
10.6.3.2.3. Lysogeny Broth
10.6.3.2.4. Protein-Free Media
10.6.3.2.5. Serum-Free Media
10.6.3.2.6. Specialty Media
10.6.3.3. Spain Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Application
10.6.3.3.1. Biopharmaceuticals and Therapeutics
10.6.3.3.2. Biotech Research
10.6.3.3.3. Cancer
10.6.3.3.4. Drug Screening and Drug Development
10.6.3.3.5. Regenerative Medicine and Tissue Engineering
10.6.3.3.6. Stem Cell Technologies
10.6.3.4. Spain Market Revenue (US$ Mn) and Forecasts, By End User
10.6.3.4.1. Biotechnology and Pharmaceutical Companies
10.6.3.4.2. Research Laboratories
10.6.3.4.3. Academic Institutes
10.6.3.4.4. Pathology Labs
10.6.4. Germany
10.6.4.1. Germany Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Reagent Type
10.6.4.1.1. Albumin
10.6.4.1.1.1.
Bovine Serum Albumin
10.6.4.1.1.2.
Human Serum Albumin
10.6.4.1.1.3.
Recombinant Human Serum
Albumin
10.6.4.1.2. Hormones
10.6.4.1.3. Attachment Factors
10.6.4.1.4. Amino Acid
10.6.4.1.5. Growth factors and Cytokines
10.6.4.1.5.1.
Tumor Necrosis Factors
10.6.4.1.5.2.
Insulin-Like Growth
Factors
10.6.4.1.5.3.
Interferons
10.6.4.1.5.4.
Interleukins
10.6.4.2. Germany Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Type
10.6.4.2.1. Chemically-Defined Media
10.6.4.2.2. Classical Media
10.6.4.2.3. Lysogeny Broth
10.6.4.2.4. Protein-Free Media
10.6.4.2.5. Serum-Free Media
10.6.4.2.6. Specialty Media
10.6.4.3. Germany Market Revenue (US$ Mn) and Forecasts, By Application
10.6.4.3.1. Biopharmaceuticals and Therapeutics
10.6.4.3.2. Biotech Research
10.6.4.3.3. Cancer
10.6.4.3.4. Drug Screening and Drug Development
10.6.4.3.5. Regenerative Medicine and Tissue Engineering
10.6.4.3.6. Stem Cell Technologies
10.6.4.4. Germany Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By End User
10.6.4.4.1. Biotechnology and Pharmaceutical Companies
10.6.4.4.2. Research Laboratories
10.6.4.4.3. Academic Institutes
10.6.4.4.4. Pathology Labs
10.6.5. Italy
10.6.5.1. Italy Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Reagent Type
10.6.5.1.1. Albumin
10.6.5.1.1.1.
Bovine Serum Albumin
10.6.5.1.1.2.
Human Serum Albumin
10.6.5.1.1.3.
Recombinant Human Serum
Albumin
10.6.5.1.2. Hormones
10.6.5.1.3. Attachment Factors
10.6.5.1.4. Amino Acid
10.6.5.1.5. Growth factors and Cytokines
10.6.5.1.5.1.
Tumor Necrosis Factors
10.6.5.1.5.2.
Insulin-Like Growth
Factors
10.6.5.1.5.3.
Interferons
10.6.5.1.5.4. Interleukins
10.6.5.2. Italy Market Revenue (US$ Mn) and Forecasts, By Type
10.6.5.2.1. Chemically-Defined Media
10.6.5.2.2. Classical Media
10.6.5.2.3. Lysogeny Broth
10.6.5.2.4. Protein-Free Media
10.6.5.2.5. Serum-Free Media
10.6.5.2.6. Specialty Media
10.6.5.3. Italy Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Application
10.6.5.3.1. Biopharmaceuticals and Therapeutics
10.6.5.3.2. Biotech Research
10.6.5.3.3. Cancer
10.6.5.3.4. Drug Screening and Drug Development
10.6.5.3.5. Regenerative Medicine and Tissue Engineering
10.6.5.3.6. Stem Cell Technologies
10.6.5.4. Italy Market Revenue (US$ Mn) and Forecasts, By End User
10.6.5.4.1. Biotechnology and Pharmaceutical Companies
10.6.5.4.2. Research Laboratories
10.6.5.4.3. Academic Institutes
10.6.5.4.4. Pathology Labs
10.6.6. Rest of Europe
10.6.6.1. Rest of Europe Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Reagent Type
10.6.6.1.1. Albumin
10.6.6.1.1.1.
Bovine Serum Albumin
10.6.6.1.1.2.
Human Serum Albumin
10.6.6.1.1.3.
Recombinant Human Serum
Albumin
10.6.6.1.2. Hormones
10.6.6.1.3. Attachment Factors
10.6.6.1.4. Amino Acid
10.6.6.1.5. Growth factors and Cytokines
10.6.6.1.5.1.
Tumor Necrosis Factors
10.6.6.1.5.2.
Insulin-Like Growth
Factors
10.6.6.1.5.3.
Interferons
10.6.6.1.5.4.
Interleukins
10.6.6.2. Rest of Europe Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Type
10.6.6.2.1. Chemically-Defined Media
10.6.6.2.2. Classical Media
10.6.6.2.3. Lysogeny Broth
10.6.6.2.4. Protein-Free Media
10.6.6.2.5. Serum-Free Media
10.6.6.2.6. Specialty Media
10.6.6.3. Rest of Europe Market Revenue (US$ Mn) and Forecasts, By Application
10.6.6.3.1. Biopharmaceuticals and Therapeutics
10.6.6.3.2. Biotech Research
10.6.6.3.3. Cancer
10.6.6.3.4. Drug Screening and Drug Development
10.6.6.3.5. Regenerative Medicine and Tissue Engineering
10.6.6.3.6. Stem Cell Technologies
10.6.6.4. Rest of Europe Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By End User
10.6.6.4.1. Biotechnology and Pharmaceutical Companies
10.6.6.4.2. Research Laboratories
10.6.6.4.3. Academic Institutes
10.6.6.4.4. Pathology Labs
10.7. Key Segment for Channeling Investments
10.7.1. By Country
10.7.2. By Reagent Type
10.7.3. By Type
10.7.4. By Application
10.7.5. By End User
11. Asia Pacific Cell Culture Media Market Analysis and
Forecasts, 2018 – 2026
11.1. Overview
11.1.1. Asia Pacific Market Revenue (US$ Mn)
11.2. Asia Pacific Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Reagent Type
11.2.1. Albumin
11.2.1.1. Bovine Serum Albumin
11.2.1.2. Human Serum Albumin
11.2.1.3. Recombinant Human Serum Albumin
11.2.2. Hormones
11.2.3. Attachment Factors
11.2.4. Amino Acid
11.2.5. Growth factors and Cytokines
11.2.5.1. Tumor Necrosis Factors
11.2.5.2. Insulin-Like Growth Factors
11.2.5.3. Interferons
11.2.5.4. Interleukins
11.3. Asia Pacific Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Type
11.3.1. Chemically-Defined Media
11.3.2. Classical Media
11.3.3. Lysogeny Broth
11.3.4. Protein-Free Media
11.3.5. Serum-Free Media
11.3.6. Specialty Media
11.4. Asia Pacific Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Application
11.4.1. Biopharmaceuticals and Therapeutics
11.4.2. Biotech Research
11.4.3. Cancer
11.4.4. Drug Screening and Drug Development
11.4.5. Regenerative Medicine and Tissue Engineering
11.4.6. Stem Cell Technologies
11.5. Asia Pacific Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By End User
11.5.1. Biotechnology and Pharmaceutical Companies
11.5.2. Research Laboratories
11.5.3. Academic Institutes
11.5.4. Pathology Labs
11.6. Asia Pacific Market Revenue (US$ Mn) and Forecasts, By Country
11.6.1. China
11.6.1.1. China Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Reagent Type
11.6.1.1.1. Albumin
11.6.1.1.1.1.
Bovine Serum Albumin
11.6.1.1.1.2.
Human Serum Albumin
11.6.1.1.1.3.
Recombinant Human Serum
Albumin
11.6.1.1.2. Hormones
11.6.1.1.3. Attachment Factors
11.6.1.1.4. Amino Acid
11.6.1.1.5. Growth factors and Cytokines
11.6.1.1.5.1.
Tumor Necrosis Factors
11.6.1.1.5.2.
Insulin-Like Growth
Factors
11.6.1.1.5.3.
Interferons
11.6.1.1.5.4. Interleukins
11.6.1.2. China Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Type
11.6.1.2.1. Chemically-Defined Media
11.6.1.2.2. Classical Media
11.6.1.2.3. Lysogeny Broth
11.6.1.2.4. Protein-Free Media
11.6.1.2.5. Serum-Free Media
11.6.1.2.6. Specialty Media
11.6.1.3. China Market Revenue (US$ Mn) and Forecasts, By Application
11.6.1.3.1. Biopharmaceuticals and Therapeutics
11.6.1.3.2. Biotech Research
11.6.1.3.3. Cancer
11.6.1.3.4. Drug Screening and Drug Development
11.6.1.3.5. Regenerative Medicine and Tissue Engineering
11.6.1.3.6. Stem Cell Technologies
11.6.1.4. China Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By End User
11.6.1.4.1. Biotechnology and Pharmaceutical Companies
11.6.1.4.2. Research Laboratories
11.6.1.4.3. Academic Institutes
11.6.1.4.4. Pathology Labs
11.6.2. Japan
11.6.2.1. Japan Cell Culture Media Market Revenue (US$ Mn) and Forecasts,
By Reagent Type
11.6.2.1.1. Albumin
11.6.2.1.1.1.
Bovine Serum Albumin
11.6.2.1.1.2.
Human Serum Albumin
11.6.2.1.1.3.
Recombinant Human Serum
Albumin
11.6.2.1.2. Hormones
11.6.2.1.3. Attachment Factors
11.6.2.1.4. Amino Acid
11.6.2.1.5. Growth factors and Cytokines
11.6.2.1.5.1.
Tumor Necrosis Factors
11.6.2.1.5.2.
Insulin-Like Growth
Factors
11.6.2.1.5.3.
Interferons
11.6.2.1.5.4.
Interleukins
11.6.2.2. Japan Market Revenue (US$ Mn) and Forecasts, By Type
11.6.2.2.1. Chemically-Defined Media
11.6.2.2.2. Classical Media
11.6.2.2.3. Lysogeny Broth
11.6.2.2.4. Protein-Free Media
11.6.2.2.5. Serum-Free Media
11.6.2.2.6. Specialty Media
11.6.2.3. Japan Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Application
11.6.2.3.1. Biopharmaceuticals and Therapeutics
11.6.2.3.2. Biotech Research
11.6.2.3.3. Cancer
11.6.2.3.4. Drug Screening and Drug Development
11.6.2.3.5. Regenerative Medicine and Tissue Engineering
11.6.2.3.6. Stem Cell Technologies
11.6.2.4. Japan Market Revenue (US$ Mn) and Forecasts, By End User
11.6.2.4.1. Biotechnology and Pharmaceutical Companies
11.6.2.4.2. Research Laboratories
11.6.2.4.3. Academic Institutes
11.6.2.4.4. Pathology Labs
11.6.3. India
11.6.3.1. India Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Reagent Type
11.6.3.1.1. Albumin
11.6.3.1.1.1.
Bovine Serum Albumin
11.6.3.1.1.2.
Human Serum Albumin
11.6.3.1.1.3.
Recombinant Human Serum
Albumin
11.6.3.1.2. Hormones
11.6.3.1.3. Attachment Factors
11.6.3.1.4. Amino Acid
11.6.3.1.5. Growth factors and Cytokines
11.6.3.1.5.1.
Tumor Necrosis Factors
11.6.3.1.5.2.
Insulin-Like Growth
Factors
11.6.3.1.5.3.
Interferons
11.6.3.1.5.4.
Interleukins
11.6.3.2. India Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Type
11.6.3.2.1. Chemically-Defined Media
11.6.3.2.2. Classical Media
11.6.3.2.3. Lysogeny Broth
11.6.3.2.4. Protein-Free Media
11.6.3.2.5. Serum-Free Media
11.6.3.2.6. Specialty Media
11.6.3.3. India Market Revenue (US$ Mn) and Forecasts, By Application
11.6.3.3.1. Biopharmaceuticals and Therapeutics
11.6.3.3.2. Biotech Research
11.6.3.3.3. Cancer
11.6.3.3.4. Drug Screening and Drug Development
11.6.3.3.5. Regenerative Medicine and Tissue Engineering
11.6.3.3.6. Stem Cell Technologies
11.6.3.4. India Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By End User
11.6.3.4.1. Biotechnology and Pharmaceutical Companies
11.6.3.4.2. Research Laboratories
11.6.3.4.3. Academic Institutes
11.6.3.4.4. Pathology Labs
11.6.4. Southeast Asia
11.6.4.1. Southeast Asia Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Reagent Type
11.6.4.1.1. Albumin
11.6.4.1.1.1.
Bovine Serum Albumin
11.6.4.1.1.2.
Human Serum Albumin
11.6.4.1.1.3.
Recombinant Human Serum
Albumin
11.6.4.1.2. Hormones
11.6.4.1.3. Attachment Factors
11.6.4.1.4. Amino Acid
11.6.4.1.5. Growth factors and Cytokines
11.6.4.1.5.1.
Tumor Necrosis Factors
11.6.4.1.5.2.
Insulin-Like Growth
Factors
11.6.4.1.5.3.
Interferons
11.6.4.1.5.4.
Interleukins
11.6.4.2. Southeast Asia Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Type
11.6.4.2.1. Chemically-Defined Media
11.6.4.2.2. Classical Media
11.6.4.2.3. Lysogeny Broth
11.6.4.2.4. Protein-Free Media
11.6.4.2.5. Serum-Free Media
11.6.4.2.6. Specialty Media
11.6.4.3. Southeast Asia Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Application
11.6.4.3.1. Biopharmaceuticals and Therapeutics
11.6.4.3.2. Biotech Research
11.6.4.3.3. Cancer
11.6.4.3.4. Drug Screening and Drug Development
11.6.4.3.5. Regenerative Medicine and Tissue Engineering
11.6.4.3.6. Stem Cell Technologies
11.6.4.4. Southeast Asia Market Revenue (US$ Mn) and Forecasts, By End
User
11.6.4.4.1. Biotechnology and Pharmaceutical Companies
11.6.4.4.2. Research Laboratories
11.6.4.4.3. Academic Institutes
11.6.4.4.4. Pathology Labs
11.6.5. Rest of Asia Pacific
11.6.5.1. Rest of Asia Pacific Cell Culture Media Market Revenue (US$
Mn) and Forecasts, By Reagent Type
11.6.5.1.1. Albumin
11.6.5.1.1.1.
Bovine Serum Albumin
11.6.5.1.1.2.
Human Serum Albumin
11.6.5.1.1.3.
Recombinant Human Serum
Albumin
11.6.5.1.2. Hormones
11.6.5.1.3. Attachment Factors
11.6.5.1.4. Amino Acid
11.6.5.1.5. Growth factors and Cytokines
11.6.5.1.5.1.
Tumor Necrosis Factors
11.6.5.1.5.2.
Insulin-Like Growth
Factors
11.6.5.1.5.3.
Interferons
11.6.5.1.5.4.
Interleukins
11.6.5.2. Rest of Asia Pacific Cell Culture Media Market Revenue (US$
Mn) and Forecasts, By Type
11.6.5.2.1. Chemically-Defined Media
11.6.5.2.2. Classical Media
11.6.5.2.3. Lysogeny Broth
11.6.5.2.4. Protein-Free Media
11.6.5.2.5. Serum-Free Media
11.6.5.2.6. Specialty Media
11.6.5.3. Rest of Asia Pacific Cell Culture Media Market Revenue (US$
Mn) and Forecasts, By Application
11.6.5.3.1. Biopharmaceuticals and Therapeutics
11.6.5.3.2. Biotech Research
11.6.5.3.3. Cancer
11.6.5.3.4. Drug Screening and Drug Development
11.6.5.3.5. Regenerative Medicine and Tissue Engineering
11.6.5.3.6. Stem Cell Technologies
11.6.5.4. Rest of Asia Pacific Cell Culture Media Market Revenue (US$
Mn) and Forecasts, By End User
11.6.5.4.1. Biotechnology and Pharmaceutical Companies
11.6.5.4.2. Research Laboratories
11.6.5.4.3. Academic Institutes
11.6.5.4.4. Pathology Labs
11.7. Key Segment for Channeling Investments
11.7.1. By Country
11.7.2. By Reagent Type
11.7.3. By Type
11.7.4. By Application
11.7.5. By End User
12. Middle East and Africa Cell Culture Media Market Analysis and
Forecasts, 2018 – 2026
12.1. Overview
12.1.1. Middle East and Africa Market Revenue (US$ Mn)
12.2. Middle East and Africa Cell Culture Media Market Revenue (US$
Mn) and Forecasts, By Reagent Type
12.2.1. Albumin
12.2.1.1. Bovine Serum Albumin
12.2.1.2. Human Serum Albumin
12.2.1.3. Recombinant Human Serum Albumin
12.2.2. Hormones
12.2.3. Attachment Factors
12.2.4. Amino Acid
12.2.5. Growth factors and Cytokines
12.2.5.1. Tumor Necrosis Factors
12.2.5.2. Insulin-Like Growth Factors
12.2.5.3. Interferons
12.2.5.4. Interleukins
12.3. Middle East and Africa Cell Culture Media Market Revenue (US$
Mn) and Forecasts, By Type
12.3.1. Chemically-Defined Media
12.3.2. Classical Media
12.3.3. Lysogeny Broth
12.3.4. Protein-Free Media
12.3.5. Serum-Free Media
12.3.6. Specialty Media
12.4. Middle East and Africa Market Revenue (US$ Mn) and Forecasts,
By Application
12.4.1. Biopharmaceuticals and Therapeutics
12.4.2. Biotech Research
12.4.3. Cancer
12.4.4. Drug Screening and Drug Development
12.4.5. Regenerative Medicine and Tissue Engineering
12.4.6. Stem Cell Technologies
12.5. Middle East and Africa Cell Culture Media Market Revenue (US$
Mn) and Forecasts, By End User
12.5.1. Biotechnology and Pharmaceutical Companies
12.5.2. Research Laboratories
12.5.3. Academic Institutes
12.5.4. Pathology Labs
12.6. Middle East and Africa Cell Culture Media Market Revenue (US$
Mn) and Forecasts, By Country
12.6.1. GCC Countries
12.6.1.1. GCC Countries Market Revenue (US$ Mn) and Forecasts, By
Reagent Type
12.6.1.1.1. Albumin
12.6.1.1.1.1.
Bovine Serum Albumin
12.6.1.1.1.2.
Human Serum Albumin
12.6.1.1.1.3.
Recombinant Human Serum
Albumin
12.6.1.1.2. Hormones
12.6.1.1.3. Attachment Factors
12.6.1.1.4. Amino Acid
12.6.1.1.5. Growth factors and Cytokines
12.6.1.1.5.1.
Tumor Necrosis Factors
12.6.1.1.5.2.
Insulin-Like Growth
Factors
12.6.1.1.5.3.
Interferons
12.6.1.1.5.4.
Interleukins
12.6.1.2. GCC Countries Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Type
12.6.1.2.1. Chemically-Defined Media
12.6.1.2.2. Classical Media
12.6.1.2.3. Lysogeny Broth
12.6.1.2.4. Protein-Free Media
12.6.1.2.5. Serum-Free Media
12.6.1.2.6. Specialty Media
12.6.1.3. GCC Countries Market Revenue (US$ Mn) and Forecasts, By
Application
12.6.1.3.1. Biopharmaceuticals and Therapeutics
12.6.1.3.2. Biotech Research
12.6.1.3.3. Cancer
12.6.1.3.4. Drug Screening and Drug Development
12.6.1.3.5. Regenerative Medicine and Tissue Engineering
12.6.1.3.6. Stem Cell Technologies
12.6.1.4. GCC Countries Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By End User
12.6.1.4.1. Biotechnology and Pharmaceutical Companies
12.6.1.4.2. Research Laboratories
12.6.1.4.3. Academic Institutes
12.6.1.4.4. Pathology Labs
12.6.2. Southern Africa
12.6.2.1. Southern Africa Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Reagent Type
12.6.2.1.1. Albumin
12.6.2.1.1.1.
Bovine Serum Albumin
12.6.2.1.1.2.
Human Serum Albumin
12.6.2.1.1.3.
Recombinant Human Serum
Albumin
12.6.2.1.2. Hormones
12.6.2.1.3. Attachment Factors
12.6.2.1.4. Amino Acid
12.6.2.1.5. Growth factors and Cytokines
12.6.2.1.5.1.
Tumor Necrosis Factors
12.6.2.1.5.2.
Insulin-Like Growth
Factors
12.6.2.1.5.3.
Interferons
12.6.2.1.5.4.
Interleukins
12.6.2.2. Southern Africa Market Revenue (US$ Mn) and Forecasts, By Type
12.6.2.2.1. Chemically-Defined Media
12.6.2.2.2. Classical Media
12.6.2.2.3. Lysogeny Broth
12.6.2.2.4. Protein-Free Media
12.6.2.2.5. Serum-Free Media
12.6.2.2.6. Specialty Media
12.6.2.3. Southern Africa Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Application
12.6.2.3.1. Biopharmaceuticals and Therapeutics
12.6.2.3.2. Biotech Research
12.6.2.3.3. Cancer
12.6.2.3.4. Drug Screening and Drug Development
12.6.2.3.5. Regenerative Medicine and Tissue Engineering
12.6.2.3.6. Stem Cell Technologies
12.6.2.4. Southern Africa Market Revenue (US$ Mn) and Forecasts, By End
User
12.6.2.4.1. Biotechnology and Pharmaceutical Companies
12.6.2.4.2. Research Laboratories
12.6.2.4.3. Academic Institutes
12.6.2.4.4. Pathology Labs
12.6.3. Rest of MEA
12.6.3.1. Rest of MEA Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Reagent Type
12.6.3.1.1. Albumin
12.6.3.1.1.1.
Bovine Serum Albumin
12.6.3.1.1.2.
Human Serum Albumin
12.6.3.1.1.3.
Recombinant Human Serum
Albumin
12.6.3.1.2. Hormones
12.6.3.1.3. Attachment Factors
12.6.3.1.4. Amino Acid
12.6.3.1.5. Growth factors and Cytokines
12.6.3.1.5.1.
Tumor Necrosis Factors
12.6.3.1.5.2.
Insulin-Like Growth
Factors
12.6.3.1.5.3.
Interferons
12.6.3.1.5.4. Interleukins
12.6.3.2. Rest of MEA Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Type
12.6.3.2.1. Chemically-Defined Media
12.6.3.2.2. Classical Media
12.6.3.2.3. Lysogeny Broth
12.6.3.2.4. Protein-Free Media
12.6.3.2.5. Serum-Free Media
12.6.3.2.6. Specialty Media
12.6.3.3. Rest of MEA Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Application
12.6.3.3.1. Biopharmaceuticals and Therapeutics
12.6.3.3.2. Biotech Research
12.6.3.3.3. Cancer
12.6.3.3.4. Drug Screening and Drug Development
12.6.3.3.5. Regenerative Medicine and Tissue Engineering
12.6.3.3.6. Stem Cell Technologies
12.6.3.4. Rest of MEA Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By End User
12.6.3.4.1. Biotechnology and Pharmaceutical Companies
12.6.3.4.2. Research Laboratories
12.6.3.4.3. Academic Institutes
12.6.3.4.4. Pathology Labs
12.7. Key Segment for Channeling Investments
12.7.1. By Country
12.7.2. By Reagent Type
12.7.3. By Type
12.7.4. By Application
12.7.5. By End User
13. Latin America Cell Culture Media Market Analysis and
Forecasts, 2018 – 2026
13.1. Overview
13.1.1. Latin America Market Revenue (US$ Mn)
13.2. Latin America Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Reagent Type
13.2.1. Albumin
13.2.1.1. Bovine Serum Albumin
13.2.1.2. Human Serum Albumin
13.2.1.3. Recombinant Human Serum Albumin
13.2.2. Hormones
13.2.3. Attachment Factors
13.2.4. Amino Acid
13.2.5. Growth factors and Cytokines
13.2.5.1. Tumor Necrosis Factors
13.2.5.2. Insulin-Like Growth Factors
13.2.5.3. Interferons
13.2.5.4. Interleukins
13.3. Latin America Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Type
13.3.1. Chemically-Defined Media
13.3.2. Classical Media
13.3.3. Lysogeny Broth
13.3.4. Protein-Free Media
13.3.5. Serum-Free Media
13.3.6. Specialty Media
13.4. Latin America Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Application
13.4.1. Biopharmaceuticals and Therapeutics
13.4.2. Biotech Research
13.4.3. Cancer
13.4.4. Drug Screening and Drug Development
13.4.5. Regenerative Medicine and Tissue Engineering
13.4.6. Stem Cell Technologies
13.5. Latin America Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By End User
13.5.1. Biotechnology and Pharmaceutical Companies
13.5.2. Research Laboratories
13.5.3. Academic Institutes
13.5.4. Pathology Labs
13.6. Latin America Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Country
13.6.1. Brazil
13.6.1.1. Brazil Market Revenue (US$ Mn) and Forecasts, By Reagent Type
13.6.1.1.1. Albumin
13.6.1.1.1.1.
Bovine Serum Albumin
13.6.1.1.1.2.
Human Serum Albumin
13.6.1.1.1.3.
Recombinant Human Serum
Albumin
13.6.1.1.2. Hormones
13.6.1.1.3. Attachment Factors
13.6.1.1.4. Amino Acid
13.6.1.1.5. Growth factors and Cytokines
13.6.1.1.5.1.
Tumor Necrosis Factors
13.6.1.1.5.2.
Insulin-Like Growth Factors
13.6.1.1.5.3.
Interferons
13.6.1.1.5.4. Interleukins
13.6.1.2. Brazil Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Type
13.6.1.2.1. Chemically-Defined Media
13.6.1.2.2. Classical Media
13.6.1.2.3. Lysogeny Broth
13.6.1.2.4. Protein-Free Media
13.6.1.2.5. Serum-Free Media
13.6.1.2.6. Specialty Media
13.6.1.3. Brazil Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By Application
13.6.1.3.1. Biopharmaceuticals and Therapeutics
13.6.1.3.2. Biotech Research
13.6.1.3.3. Cancer
13.6.1.3.4. Drug Screening and Drug Development
13.6.1.3.5. Regenerative Medicine and Tissue Engineering
13.6.1.3.6. Stem Cell Technologies
13.6.1.4. Brazil Cell Culture Media Market Revenue (US$ Mn) and
Forecasts, By End User
13.6.1.4.1. Biotechnology and Pharmaceutical Companies
13.6.1.4.2. Research Laboratories
13.6.1.4.3. Academic Institutes
13.6.1.4.4. Pathology Labs
13.6.2. Rest of Latin America
13.6.2.1. Rest of Latin America Cell Culture Media Market Revenue (US$
Mn) and Forecasts, By Reagent Type
13.6.2.1.1. Albumin
13.6.2.1.1.1.
Bovine Serum Albumin
13.6.2.1.1.2.
Human Serum Albumin
13.6.2.1.1.3.
Recombinant Human Serum
Albumin
13.6.2.1.2. Hormones
13.6.2.1.3. Attachment Factors
13.6.2.1.4. Amino Acid
13.6.2.1.5. Growth factors and Cytokines
13.6.2.1.5.1.
Tumor Necrosis Factors
13.6.2.1.5.2.
Insulin-Like Growth
Factors
13.6.2.1.5.3.
Interferons
13.6.2.1.5.4.
Interleukins
13.6.2.2. Rest of Latin America Cell Culture Media Market Revenue (US$
Mn) and Forecasts, By Type
13.6.2.2.1. Chemically-Defined Media
13.6.2.2.2. Classical Media
13.6.2.2.3. Lysogeny Broth
13.6.2.2.4. Protein-Free Media